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About the Enzyme Cofactor, Pyrroloquinoline Quinone 
Pyrroloquinoline quinone (PQQ) is a relatively small (330 Da) tricyclic o-quinone 
that has garnered a great deal of research attention since its interactivity with a bacterial 
aldose sugar dehydrogenase was first reported in 1964.1 Since the discovery of PQQ, the 
list of "intrigues and intricacies" surrounding the prokaryotic and eukaryotic 
biochemistries associated with the molecule has continued to grow.2 
Early on, the recognition and classification of PQQ as a proteinaceous quinone 
enzyme cofactor was delayed as it was, and still remains, the only known (poly)peptide-
derived quinone cofactor that is not formed in situ through post-translational modification 
of the enzyme polypeptide.2, 3 Instead, it is non-covalently and reversibly bound to its 
various cognate dehydrogenase enzymes, and is synthesized separately from a 
ribosomally synthesized peptide.2-6 In all other, and more recently discovered, 
proteinaceous quinone cofactors (e.g. trihydroxyphenylalanine quinone (TPQ)7 reported 
in the early 1990s, tryptophan tryptophylquinone (TTQ)8 also reported early in the 1990s, 
lysyl tyrosine quinone (LTQ)9 reported in 1996, and cysteine tryptophylquinone (CTQ)10 
reported in 2001), the cofactor is the result of post-translational modifications to the 
amino acids of the enzyme active site, which is either self-catalyzed or requires additional 
biosynthesis enzymes (Figure 1).2 
  2 
 
Figure 1. PQQ along with other quinone cofactors. 
 
Regarding PQQ, because it is now known to share significant qualities with other 
ribosomally produced and post-translationally modified peptides (RiPPs),11 classification 
as a unique quinone cofactor may have been premature; perhaps it is better classified, not 
so much as a proteinaceous quinone cofactor, but as a quinone RiPP. 
Gram-negative bacteria represent the majority of species that synthesize PQQ; among 
these is Klebsiella pneumoniae, infamous among human pathogens as responsible for 
nosocomial infections and the first known pan-resistant (resistant or non-susceptible to all 
available antimicrobial drugs) bacterial pathogen.12, 13 Some bacteria that do not make 
PQQ encode PQQ-dependent aldose sugar/alcohol dehydrogenases in their genomes, 
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which are expressed under specific nutrient conditions and provide a growth advantage, 
thus making PQQ a bacterial vitamin.14-17 
Very recently, data indicated that a eukaryote mushroom, Coprinopsis cinerea, may 
also require PQQ as a coenzyme for a sugar oxidoreductase, even though no PQQ 
biosynthetic operon (pqq operon) exists in eukaryotes.18 More intriguing is the fact that 
dietary deprivation in higher eukaryotes, like mice and rats, leads to fertility dysfunction 
and neonatal growth retardation.19-22 Similar experiments also linked PQQ-eliminating 
diets in rats to memory and cognition problems.23 
The biochemistry behind the probiotic roles of PQQ in higher organisms is not as 
understood as are its roles in bacterial dehydrogenases. It is known that PQQ is a potent 
antioxidant (100 times more efficient than ascorbic acid when measured by the number of 
redox cycles accomplished on a molar basis), and this ability is strongly linked to 
increases in mitochondriogenesis and mitochondrial health.24-33 In bacterial pathways, the 
electrons liberated from the PQQ ⇄ PQQH2 redox cycle are used to generate ATP in the 
constituent electron transport chains of the organisms. 
Natural Products and their Differing Biosyntheses 
While the term 'RiPP pathway' is still seen in literature, pathways that produce RiPPs 
are now referred to as post-ribosomal peptide synthesis pathways (PRPS), because they 
tailor a precursor peptide that was first synthesized by the ribosomal machinery of the 
cell.11 
Compared to other prevalent natural product pathway classifications (e.g. terpenoid 
biosynthetic pathways, alkaloid biosynthetic pathways, polyketide biosynthetic pathways, 
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and non-ribosomal biosynthetic pathways), PRPS pathways are relatively simple.11 
Because the bulk of the work is performed by the polymerization activities of the 
ribosome, the additional enzymes necessary for completing a RiPP are few in comparison 
to, for example, nonribosomal pathways (NRPs), which require at least one additional 
enzyme (or catalytic domain) for each peptide residue added. For the purpose of 
comparison, biosynthesis of the 12-residue, cyclized and branched NRP, bacitracin, 
requires 12 enzyme modules with a total of 40 catalytic domains.34 A search of the 
GenBank database (www.ncbi.nlm.nih.gov/genbank/) shows that only 4 gene products 
(McjA, B, C, and D) are needed for completion of the 21-residue, cyclized, branched, and 
knotted RiPP, microcin J25 (Figure 2). 
 
Figure 2. (Left) The antibiotic NRP, bacitracin, with Zn-coordinated geranyl 
pyrophosphate (GPP) outlined with a dashed contour (PDB 1PP5) compared to 
(Right) the RiPP, microcin J25 (PDB 1PP5). 
 
 
While all of these classes of natural product biosynthesis offer possible avenues for 
engineering novel products, RiPPs, while every bit as diverse in size, chemical 
complexity, and function, are biosynthesized with relative cellular simplicity, fueling an 
interest in exploring this specific biosynthetic class. Through structural studies, the 
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Wilmot Lab is contributing to the understanding of the PQQ PRPS, and by extrapolation, 
the understanding of PRPSs in general. 
About PRPSs 
RiPPs as well as their respective PRPS pathways are incredibly diverse, and a large 
collaboration recently standardized RiPP/PRPS nomenclature and classified the 
RiPPs/PRPSs based on natural product characteristics (Table 1).11, 35-41 The diverse 
wealth of natural products listed in this table serves to illustrate the potential this 
biosynthetic class promises, not only for the richness of products present, but because of 
the possible novel products that can arise through bioengineering efforts. 
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Table 1. PRPS classifications based on pathway or RiPP characteristics 
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While the produced natural products are very diverse, there are significant 
commonalities between the PRPS classifications, the four most significant of these 
commonalities follow: 
1) All RiPPs begin as a ribosomally synthesized precursor peptide.11 
2) Precursor peptides are most often bipartite (with an N-terminal, leader portion used for 
recognition, and a C-terminal, core portion providing the amino acids that will eventually 
comprise the completed RiPP).11 
3) The tailoring machinery required to complete biosynthesis is comparatively simple.11 
4) PRPS pathway gene products often include a peptide-recognizing and presenting 
protein fold, the RiPP recognition element (RRE).42 
There is much diversity in the RiPP precursor peptides. In some (e.g. PqqA in the 
PQQ PRPS), only a small number of the residues (two) out of the entire core sequence 
end up in the final natural product, while in others (McjA in the microcin J25 PRPS), the 
entire core sequence is included in the final product.43 The length of these peptides also 
varies greatly.11 In some precursor peptides, RRE recognition and presentation require 
only a leader portion (e.g. PQQ), while in others, a C-terminal recognition sequence is 
also required (e.g. cyanobactins, amatoxins, cyclotides, and orbitides).11 
RREs occur in the majority of PRPS pathways.11, 42 Most often, the RRE is N-
terminally attached to the first tailoring enzyme, but occasionally, as is the case with 
PqqD and MtfB of mycofactocin biosynthesis, the RRE is a small, independent 
scaffolding protein (Figure 3).42, 44 
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Figure 3. In this figure from Burkhart, et al., 2015,42 protein domains are shown to 
scale. The eleven RiPP classes shown represent a subset of the classes mentioned in 
the Arnison, et al., 2013 review that include RREs. Only 3 out of 11 of the 
represented classes have C-terminal RREs, and the RRE is separate from the first 
enzyme in only 2 out of 11. 
  
  9 
The PQQ Pathway in Particular  
Studies involving the biosynthesis of PQQ are ongoing, and some of the enzyme 
functions within the pathway are better defined than others, but it is known that five gene 
products from the pqq operon are required for PQQ production.2 
It is also well understood that all of the carbons and nitrogens of PQQ come from two 
absolutely conserved residues (Glu and Tyr) found in the C-terminal core portion of the 
precursor peptide, PqqA (Figure 4).2 
 
Figure 4. Carbons and nitrogens in PQQ derive from a Glu and Tyr in the bipartite, 
precursor peptide. 
 
PqqD recognizes, binds, and presents PqqA to the first enzyme of the pathway, PqqE. 
PqqD is a separate protein in most PQQ pathways (including that of Klebsiella 
pneumoniae), but is C-terminally fused to PqqC in Methylobacterium extorquens PqqCD 
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(MePqqCD). For my dissertation work, I used an artificially truncated PqqD (MePqqD). 
Later in this discussion I will also mention the PqqC truncation (MePqqC). 
PqqE is a member of the radical S-adenosyl methionine (rSAM) enzyme superfamily 
with a C-terminal SPASM (subtilosin, PQQ, anaerobic sulfatase, and mycofactocin) 
domain.2 This attached domain is so named for the PRPS pathways that have initiating 
rSAMs that have also been found to contain the novel domain.2 PqqE is known to 
perform Glu-to-Tyr cross-linking.45 While the chemical structure of the final product of 
PqqE is not currently defined, the rSAM enzyme most likely produces a molecule that is 
passed to PqqB for further tailoring.2 PqqB, then, is thought to produce the substrate for 
PqqC, 3α-(2-amino-2-carboxyethyl)-4,5-dioxo-4,5,6,7,8,9-hexahydroquinoline-7,9-
dicarboxylic acid (AHQQ).2 In this dissertation, the product of PqqE, and the unknown 
substrate for PqqB, will be referred to as pre-AHQQ. 
Early pqqB knockout studies were inconclusive regarding the requirement for the 
gene product, PqqB, in PQQ biosynthesis.2 More recent bioinformatic analyses, however, 
point to the gene playing an essential role in PQQ production.2 In unpublished work by 
our collaborator, Prof. Judith Klinman (University of California, Berkeley), PqqB, a 
homodimer, appears to be a monocopper-dependent oxygenase, a first for the metallo-β-
lactamase superfamily to which it belongs. By sequence identity, the most closely related 
crystal structure is that of the dimanganese-dependent phosphodiesterase, PhnP.46 It has 
already been noted that PqqB had lost one of the conserved residues of the dimetal 
binding site, and likely contained a monometal active site.12 This has been confirmed in 
unpublished work from the Wilmot Lab, but the expected metal ion, Mn2+, bound 
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weakly, and the most prevalent substitute for manganese, Fe2+, did not bind at all. A 
PqqB structure was subsequently shown to bind copper with much higher affinity, and 
the crystal structure solved with copper in the catalytic center. If PqqB is copper-
dependent, it would be the first enzyme from that superfamily to use copper. 
Early in my graduate work, I was able to trap a putative pre-AHQQ mimic, 5-S-
cysteinyl-DOPA (5cysDOPA), in the active site of Pseudomonas putida PqqB with a 
coordinated Zn2+ at the catalytic core (Figure 5). Zinc is commonly used as a non-
reactive metal substitute in the study of copper-dependent redox enzymes. The 
5cysDOPA has a thioether bond in place of the C-C bond expected as the result of PqqE 
catalysis and contains only two coordinating carboxyl moieties. This allowed the mimic 
to occupy multiple coordination conformations, which could not be satisfactorily 
modeled. This ambiguity in metal coordination has led to more recent efforts to trap 
mimics more similar to the expected structure of pre-AHQQ by another graduate student 
in the Wilmot Lab, Chao Li. Abbreviated collection and refinement statistics for my 
unpublished PqqB–5cysDOPA structure are provided (Table 2). Further PqqB work is 
not included in this dissertation. 
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Figure 5. PqqB is thought to convert a pre-AHQQ molecule (putative) to AHQQ 
(A). The putative pre-AHQQ shown has not been successfully synthesized, therefore 
5-S-cysteinyl-DOPA was used as a substrate mimic (B). Two views of the PqqB 
active site (C). Positive difference density during structural refinement indicates 
that when crystallized with Zn, PqqB binds 5-S-cysteinyl-DOPA non-
specifically. The electron density illustrated here (gray mesh) shows the Fo-Fc map 
generated by RefMac5 (CCP4 suite).  The ray traced density was produced using 
PyMOL at sigma = +3.0 and carve = 2.5.  Two of many possible positions for 5-S-
cysteinyl-DOPA are modeled in green and cyan, coordinating residues from PqqB 
are yellow, zinc is depicted as a gray sphere, the oxygen from a coordinated water is 
depicted as a red sphere. 
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Table 2. PqqB–5cysDOPA abbreviated statistics 
 
aWhen used, values in parentheses are for 
the outer/highest resolution shell. bRfree is 
the R factor based on 5% of the data 
excluded from refinement. 
 
PqqC is the final and best characterized enzyme in the PQQ biosynthetic pathway.47-
49 It is an oxidase that catalyzes an 8-electron cyclization and oxidation of its substrate, 
AHQQ, to the final product of the pathway, PQQ (Figure 6).50 It accomplishes catalysis 
by activating O2 in the absence of either an external cofactor or a metal, through a 
progression of PqqC conformational changes, from an open resting enzyme to closed 
product complex.48-50 These conformation changes reposition multiple, coordinating 
residues, including basic amino acids required for proton abstractions (tautomerization 
steps of B1, B2, and B3 in Figure 6 and panel C in Figure 7).50 Fully open and fully closed 
structures for Klebsiella pneumoniae PqqC (KpPqqC) have been solved 
crystallographically (Figure 7).49, 51 My work on MePqqCD and the truncation, MePqqC, 
involved finding alternative crystal morphologies for in crystallo trapping of catalytic 
intermediates. The search for alternative crystal morphologies, other than that already 
published for KpPqqC, began after our failed attempts to crystallize wild type KpPqqC in 
a form that could bind PQQ and undergo PqqC closure following addition of PQQ to the 
crystal containing solution failed. The inability to replicate published KpPqqC 
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crystallization conditions that were reported to support the PqqC structural changes, 
puzzled us until earlier this year (January 2017), when I noticed that the deposited "wild 
type" crystal structures (PDB IDs 1OTV and 1OTW) are actually A21D mutants.49 The 
Asp21 residue appears to play a critical role in crystal packing, leading to a P21212 space 
group, and explains why our true wild type (Ala21) packed as I222 and did not bind PQQ 
during crystal soaking experiments. Additionally, unpublished soak experiments by a 
former Wilmot Lab postdoc, Val Klema, using crystals of two mutants of KpPqqC 
(R179S and Y175F), demonstrated binding to PQQ, but both failed to adopt the fully 
closed conformation of the PqqC product complex (Figure 8). KpPqqC Y175F has been 
demonstrated to adopt a fully closed conformation when co-crystallized with PQQ, but 
R179S is known to lead to a more open conformer.52 However, KpPqqC Ala21 is a 
surface residue not involved in the active site, and so efforts are now ongoing to 
crystallize the A21D KpPqqC mutant to reproduce the crystal form suitable for trapping 
catalytic intermediates “on-the-fly” in PqqC crystals. 
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Figure 6. Proposed PqqC mechanism by our collaborators in the Klinman Lab, U.C. 
Berkeley. AHQQ is represented at the top-left, and PQQ at the bottom-right.  Each 
row represents one of four 2-electron oxidation steps that correspond to progressive 
closure of the enzyme. This figure was adapted from scheme 1 in the paper by 
Bonnot, et al., 2013.50 
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Figure 7. KpPqqC in its open (A) and closed (B) conformations, corresponding to 
resting enzyme and product complexes, respectively, along with some of the largest 
movements of active site residues (C) when going from open (green) to closed (cyan). 
 
 
Figure 8. Overlay of KpPqqC Y175F soaked in a PQQ-containing solution (green) 
and the KpPqqC Y175F-PQQ co-crystallization complex (grey) of Puehringer et al 
(2010) (PDB ID 3HLX).52 Helices 5 and 6 remain disordered in the PQQ soak 
experiments, but close in the co-crystallization. 
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The putative protease, PqqF, while not always present in the pqq operon, appears to 
play a role that can be performed by other proteases, as PQQ biosynthesis still occurs 
with no phenotypic consequences when the pqqF gene is knocked out in organisms that 
contain it.2, 18 
In summary, the PQQ biosynthetic pathway begins when PqqD recognizes and 
presents the ribosomally-produced peptide, PqqA, to the first tailoring enzyme, PqqE. 
Where the putative protease, PqqF, acts in the pathway is not known, and it could 
conceivably follow PqqE, excising the cross-linked Glu-Tyr from the PqqA peptide, or it 
could follow PqqB, a putative copper-dependent oxygenase. Although these steps still 
need to be defined, the result is AHQQ, which is finally oxidized to PQQ by PqqC. 
Research significance and specific aims 
Because of its predominant production by Gram-negative pathogens, the PQQ 
biosynthetic pathway was initially considered a possible target for novel antibiotic 
development. More recent scientific interest has centered on PQQ biosynthesis as a 
model pathway for PRPS natural products. The specific aims of my research have 
focused on the initiating and final steps of PQQ biosynthesis. Initiation involves the 
RRE, PqqD, binding the precursor peptide, PqqA, for presentation to the first tailoring 
enzyme, PqqE. The RRE-precursor peptide interaction is found in the majority of PRPS 
pathways, and the natural separation of RRE from enzyme encountered in the PQQ and 
mycofactocin pathways makes it ideal for structural studies by nuclear magnetic 
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resonance (NMR).44, 45, 53 The final step in the pathway is the conversion of the 
intermediate, AHQQ, to the final natural product, PQQ, catalyzed by PqqC. 
The initiating steps of PQQ biosynthesis provide novel opportunities to explore 
emerging biochemistry. rSAM-SPASM enzymes are widespread, with ~14000 
annotations in the Interpro sequence database (https://www.ebi.ac.uk/interpro/) and these 
are often associated with PRPSs. The prevalence of rSAM enzymes in RiPP biosynthesis 
is very likely linked to the ability of radicals to initiate difficult chemistries such as 
oxidative decarboxylation,53, 54 thioether bond formation,55-60 and the C-C bond formation 
required for Glu–Tyr crosslinking in PQQ biosynthesis.2, 45, 61 Bioinformatics suggests 
that ∼50% of all PRPS rSAM-SPASM enzymes have an identifiable N-terminal RRE 
domain as part of the polypeptide, although in PQQ, the RRE is present as a separate 
protein. The final RiPP products from PRPSs that feature rSAM-SPASM enzymes are 
chemically diverse with a wide range of physiological functions: antibiotic (thurincin H 
and subtilosin A), growth regulation (sporulation killing factor), signaling (streptide), and 
redox cofactors (PQQ).11 
Unfortunately, the only crystal structure of a rSAM-SPASM enzyme is that of 
anSME, which is not part of a RiPP pathway but activates a sulfatase under anaerobic 
conditions through post-translational modification.62 Therefore, the structural details of 
how peptide substrates are presented to the prevalent rSAM-SPASM enzymes found 
within diverse RiPP biosynthesis pathways are currently unknown. The results presented 
in chapters 2 and 3 of this dissertation provide crucial insights into RRE interactions 
between precursor peptides and the prevalent rSAM-SPASM enzymes of RiPP pathways, 
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while that of chapter 4 focuses on crystal structures of MePqqCD and MePqqC as steps 
towards trapping catalytic intermediates in PqqC crystals. 
Three aims of my research 
1. Solving the structure of PqqD. While a non-physiological, domain-swapped 
dimeric form of Xanthomonas campestris PqqD (XcPqqD) exists in the PDB, no 
monomeric (physiological) structure existed.63 A structure of MePqqD would not only be 
the first physiological structure for PqqD proteins in general, but also the first structure of 
a stand-alone RRE across all PRPS pathways. 
2. Identify binding surface residues on PqqD. I desired to learn how PqqD binds to 
PqqA, and how PqqD + PqqA together bind to PqqE. The majority of PRPSs include 
RREs with a fold very similar to that of PqqD, but only a few of these are 
independent/stand-alone RREs; most RREs are domains of the first tailoring enzyme. I 
wanted to compare this novel, independent RRE to known/deposited constituent RREs in 
complex with precursor peptides within the PDB, to learn similarities and differences in 
peptide binding and presentation in PRPS pathway initiation. Additionally, I wanted to 
define how the RRE interacted with a rSAM-SPASM enzyme, an interaction where there 
is currently no structural information. 
3. Crystallize and solve structures of MePqqCD and the MePqqC truncation. 
Multiple structures for KpPqqC have been deposited in the PDB, including bound and 
unbound forms of wild type (with a A21D surface mutation) and active site mutants. 
What has not been accomplished is the trapping in crystallo of AHQQ-to-PQQ 
intermediates in the PqqC active site. Structures with trapped intermediates would 
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elucidate mechanistic details for how PqqC catalyzes the conversion of AHQQ to PQQ. 
To this end, I turned to MePqqCD and MePqqC. 
Methods in Structural Biology 
Overview 
Whether a protein functions as a structural building block, scaffold for mediating 
protein-protein or protein-biomolecule interactions, hormone, receptor, reaction-
catalyzing enzyme, or any other function(s) from a long list of possibilities, proteins are 
at the very heart of biochemistry, and a three-dimensional structure elucidating the 
placement and relationship of the constituent atoms is vital to understanding intra- and 
interactivities with other biomolecules. An analogy can be drawn between studying 
protein structures (using techniques like X-ray crystallography (XRC), nuclear magnetic 
resonance (NMR), and/or cryo-electron microscopy (CEM)) and interacting with an 
automobile; one can learn to drive a car without taking it apart, but one will never really 
understand how to fix the car, unless one removes and studies each and every part. 
Techniques like XRC, NMR, and CEM allow structural biologists to do just that, to 
extrapolate from the detailed structures of proteins how they work, while gaining deeper 
understanding of function and molecular interactions. Structural biology with its 
corresponding biophysical techniques is a crucial part of understanding life, the 
mechanisms of disease, and even rationally engineering vaccines, drugs, and 
biotechnological tools from our structural knowledge of proteins. 
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X-ray Crystallography 
Protein XRC is predicated upon obtaining a protein sample of sufficient purity and 
solubility to allow for screening experiments of multiple variables aimed at discovering 
the––often very specific––conditions under which that protein will form crystals.64 These 
variables include protein construct and concentration, buffer compositions, pH, 
temperature, precipitant concentrations and compositions, time, and so forth.64 
The very short wavelengths useful for structural determination diffract well enough to 
solve structures at resolutions as high as 0.5 Å, but these energies interact weakly with 
the small amount of matter, specifically electrons, in a single protein. This limitation is 
overcome by the amplification effect provided by the very large number of protein 
molecules contained in a protein crystal. Once a growth condition is found to produce 
protein crystals, the crystals are screened to determine the quality of diffraction (Figure 
9). External indicators such as optical clarity, color, size, and shape are not reliable 
predictors for diffraction quality. While larger crystals contain more protein and therefore 
greater diffraction amplification than their smaller counterparts, in some morphologies, 
larger crystals provide more opportunity for diffraction-degrading misalignments and 
imperfections in the lattice, leading to poor diffraction.64 In the end, the process of 
finding specific conditions that lead to suitably-diffracting crystals, can take weeks, 
months, years, or even fail (Figure 10). Intrinsically disordered proteins by their very 
nature are unsuitable subjects for XRC as they tend to not form highly-ordered crystals. 
Cryo-cooling crystals to reduce radiation damage during the experiments can also lead to 
reduced diffraction quality. 
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Figure 9. Diffraction quality. Subtle misalignments in crystal packing leading to 
spot smearing or mosaicity (A) make peak integration difficult or impossible. 
Multiple crystal lattices superimposed on top of one another (B) can be caused when 
crystals grow into one another, or could simply mean that multiple crystals were 
harvested together, accidentally. The portions of the diffraction seen in panels A and 
B show strong ice rings, which obscure reflections. While not perfect, diffraction 
patterns with minimal mosaicity or icing, and clear, round reflections (C) can be 
converted into interpretable electron density. A concept not directly illustrated in 
this figure is that of resolution. Reflections farther from the center represent higher 
resolution data (more structural detail), and that is also considered a metric of 
diffraction quality. 
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Figure 10. MePqqCD crystal morphologies. After broad screening for 
crystallization at the UMN Kahlert Structural Biology Laboratory's crystal 
screening facility, multiple "hits" lead to dozens of variable combinations to pursue. 
While the crisp, optically-clear, 600 µm crystal in the upper right pane (outlined for 
clarity) was visible to the naked eye, its diffraction was inferior to smaller crystals of 
a different morphology (not pictured) that led to the 2.85 Å structure presented in 
chapter 4 of this dissertation. 
 
Provided that a given protein can be crystallized and sufficient, high quality 
diffraction data can be collected, another hurdle remains for the crystallographer, that of 
solving the phases for the thousands of reflections that comprise a dataset. While the 
detector can collect information about the position of an individual spot (relates to 
specific hkl planes in the crystal lattice) and intensity (relates to the quantity of electron 
density (matter) in that plane), no detector can measure the phases of the diffracted 
photons associated with that spot, and yet, that phase information is even more critical to 
creating an the electron density map than the position and intensity data collected by the 
detector (Figure 11).64 This is what is known as the "phase problem" in XRC.64, 65 
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Figure 11. Solid state detectors cannot detect the phases of the diffracted photons. 
Graphic was co-developed by the author and Matthew Jensen for 2015–2016 
presentations given to Dr. Larry Que's Chemical Biology of Enzymes, CHEM 8412, 
at UMN. 
 
There are many methods that can be employed to solve the phase problem, from more 
involved, de novo methods, such as single- or multi-wavelength anomalous diffraction 
(SAD or MAD), to relatively simple methods, like molecular replacement, where phases 
are essentially "borrowed" from a previously-solved, homologous protein structure and 
then refined to a statistically-guided endpoint.64-66 Fortunately, for both of the PqqC 
structures presented in this research, phases from a close homologue were used 
successfully. Details for the two PqqC structures' initial data quality and refinement 
statistics are provided in chapter 4. 
NMR 
Similar to XRC, solution NMR experiments require sufficient concentrations of 
purified––and usually isotopically-labelled––protein in buffer conditions that do not 
suppress or interfere with the detection of resonance signals; ionic salts like sodium 
chloride can suppress signal (Figure 12). For proteins where structural stability requires 
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buffer conditions with relatively high ionic strength, this can present a challenge. 
Fortunately, the PqqD in our research remained in solution at concentrations upward of 
10 mg/ml without signal degrading salts (e.g. NaCl and KCl) through the use of a simple, 
non-interfering buffer (25 mM potassium phosphate). As with XRC, some proteins are 
not suited for solution NMR due to solubility, and the complexity of NMR spectra limit 
the size of protein that can be studied. 
 
Figure 12. NMR signal sensitivity and therefore, signal-to-noise, diminishes with 
increasing salt concentrations. Figure from data collected by collaborator, Dr. 
Youlin Xia, on a Minnesota NMR Center 700 MHz instrument equipped with a 
5mm TXI cryoprobe. 
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When atoms with a nuclear spin quantum number (m)––those with an odd number of 
nucleons (protons and neutrons), such as 1H, 13C, and 15N––are placed in a strong 
magnetic field (Bo), a couple of things happen; 1) the energy gap between nuclei in the 
low energy spin state (m = +1/2) and those in the high energy spin state (m = -1/2) 
separates and broadens (Figure 13), and 2) the nuclear magnetic spins begin to precess 
(wobble) at a specific frequency known as the Larmor frequency.67 
 
Figure 13. Zeeman Effect. Magnetic field-induced splitting and broadening for the 
energy states in nuclear spin. 
 
The perturbation of these precessing nuclear magnetic spin resonances lies at the 
heart of NMR, and the energy-gap splitting and broadening effect, called the Zeeman 
effect, amplifies the ability to "see" these perturbations, because the stronger the 
magnetic field, the greater the effect (Figure 13).67 Broadening of these energy 
differences is directly tied to the sensitivity of the NMR instrument and peak-resolving 
power.67 Stronger magnets (NMR instruments are often referred to as, simply, magnets) 
provide sharper peaks and are able to resolve spectra where smaller magnets might fail. 
Larger molecules (i.e. proteins) tumble more slowly in solution than smaller molecules, 
and this slower tumbling leads to peak broadening.67 This is why larger NMR instruments 
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(upward from 650 MHz) are most used for macromolecular studies, while smaller 
instruments (650 MHz and smaller) may be employed for simpler, organic molecules. 
Time is also a factor in resolving power, as a large number of repeated spectra collected 
over a longer period of time, when averaged, improves signal-to-noise, thus sharpening 
peaks and potentially getting around the need for a bigger magnet. As instrument time is 
precious, striking a balance between longer repeat experiments on a smaller magnet 
versus shorter duration experiments on a larger magnet must be weighed against machine 
availability, cost of operation, and so forth. For most of the experiments presented in this 
study, which required 2D and 3D spectrum collection, the 850 and 900 MHz instruments 
at the Minnesota NMR Center were used, but quick (30 minute) 1H,15N-HSQCs to 
monitor protein stability/degradation were often performed on a 700 MHz instrument. 
NMR experiments consist of very specific pulse sequences consisting of timed bursts 
of electromagnetic energy at FM-radio frequencies, geometrically induced orthogonal to 
Bo.67 When matching (resonating with) the Larmor frequency of a specific nuclei (e.g. 
1H, 13C, and 15N), the magnetic wave component of the electromagnetic pulse perturbs 
that nucleus's magnetic spin precession, causing an unnatural number (higher than the 
number attributed to the normal Boltzmann distribution) of nuclei to experience spin 
inversion, effectively knocking nuclei to the higher energy (m = -1/2) spin state.67 The 
instrument then detects the decay times as the perturbed atoms return to their pre-
perturbed, normal distribution energy states (m = +1/2); this is the free induction decay 
(FID) signature, and it looks like a damped sinusoidal oscillation.67 Performing a Fourier 
transform (FT) on an FID effectively converts the spectra from the time domain to the 
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frequency domain allowing us to observe peaks representing individual atoms or specific 
atom-to-atom relationships (Figure 14).67 Once converted to the frequency domain, the 
frequencies are normalized to 'parts per million' notation (ppm or δ), allowing for spectra 
from any instrument of any magnetic strength to be compared to any other instrument's 
spectra.67 
By combining coordinated NMR pulse sequences into multi-dimensional experiments 
that take advantage of specific nuclear Larmor resonances in the macromolecule, spectral 
peaks representing individual atoms can be identified, and 1-, 2-, and 3-dimension 
positional relationships between atoms can be deduced. Resonance interactions can 
propagate through bonds or through space.67 When resonance interactions occur through 
space, they are called Nuclear Overhauser Effects (NOEs).67 These positional 
relationships along with knowledge of the primary sequence of the protein, allow for 
deductive assignment of peaks and can ultimately lead to structural determination. 
In addition to structural studies, NMR can be used to elucidate protein-
protein/substrate interactions. By observing peak shifts induced by adding binding 
partners, residues involved in binding can be identified.67 
  29 
 
Figure 14. From the time domain to the frequency domain. Showing sample FIDs 
for one, two, and multiple atoms Fourier transformed to the frequency domain, the 
form that we read and interpret in NMR. 
 
Details for the PqqD experiments leading to the initial deposition of peak assignments 
are provided in chapter 2, and final experiments leading to a PqqD solution structure and 
identifying binding residues for PqqD + PqqA are provided in chapter 3.  
Method Selection 
For our research, our method selection was guided by necessity; we chose the method 
that worked. The MePqqD (~10 kDa) protein initially proved so difficult to crystallize 
that NMR was alternatively, and successfully, employed. On the other hand, PqqC (~29 
kDa), both in the form of a natural fusion (MePqqCD) and as an artificial truncation 
(MePqqC domain only), crystallized more readily, and their structures were determined. 
In general, XRC can determine larger protein structures and protein complexes, while the 
strength of solution NMR lies in smaller protein structures, and studies involving protein 
dynamics. While CEM was not employed in my dissertation research, it is emerging as 
the go-to method for very large and membrane-bound proteins and protein complexes. 
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Spin-off methods to the 'big three' methods mentioned above, such as solid state NMR 
and neutron diffraction crystallography, fill other specialty niches in the tool belts of 
structural biologists, with unique capabilities and corresponding 
advantages/disadvantages. 
Experimental Overview 
In chapters 2 and 3, solution NMR was used to determine the first physiological 
structure for an independent RRE (MePqqD) in a PRPS pathway, and to determine which 
residues of the RRE are involved in recognizing and binding the precursor peptide 
(MePqqA) and the first tailoring enzyme of the PQQ biosynthetic pathway, PqqE. 
In chapter 4, XRC was used to determine the structure of the final enzyme in the 
pathway, MePqqC, from two different variant proteins: first, from the natural MePqqCD 
fusion, and second, from the artificial MePqqC-domain only truncation. 
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Paper 1 Abstract 
The ribosomally synthesized and post-translationally modified peptide (RiPP), 
pyrroloquinoline quinone (PQQ), is a dehydrogenase cofactor synthesized by, but not 
exclusively used by, certain prokaryotes. RiPPs represent a rapidly expanding and diverse 
class of natural products––many of which have therapeutic potential––and the 
biosynthetic pathways for these are gaining attention. Five gene products from the pqq 
operon (PqqA, PqqB, PqqC, PqqD, and PqqE) are essential for PQQ biosynthesis. The 
substrate is the peptide PqqA, which is presented to the radical SAM enzyme PqqE by the 
small protein PqqD. PqqA is unstructured in solution, and only binds to PqqE when in 
complex with PqqD. PqqD is a member of a growing family of RiPP chaperone proteins 
(or domains in some cases) that present their associated peptide substrates to the initial 
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RiPP biosynthesis enzymes. An X-ray crystal dimer structure exists for Xanthomonas 
campestris PqqD (PDB ID: 3G2B), but PqqD is now known to act as a monomer under 
physiological conditions. In this study, the PqqD truncation from naturally fused 
Methylobacterium extorquens (Me) PqqCD was overexpressed in Escherichia coli and 
MePqqA was chemically synthesized. Solution NMR 1H-,15N-HSQC chemical shift 
studies have identified the PqqD residues involved in binding PqqA, and 1H, 13C, and 15N 
peak assignments for PqqD alone and for PqqD bound to PqqA are described herein. 
Introduction (Biological context) 
4,5-Dihydro-4,5-dioxo-1H-pyrrolo[2,3-f] quinolone-2,7,9-tricarboxylic acid 
(pyrroloquinoline quinone or PQQ), is a ribosomally synthesized and post-translationally 
modified peptide (RiPP) that acts as a dehydrogenase cofactor for certain alcohol and 
aldose sugar dehydrogenases in prokaryotes.16, 17 Five gene products from the pqq operon 
are required for PQQ biosynthesis.12 Two of these five products, PqqA, a 20 to 30 residue 
peptide with an absolutely conserved EXXXY sequence near its C-terminal end,68-71 and 
PqqD, which tightly binds PqqA and forms a ternary complex with PqqA and PqqE,44 are 
the focus of the NMR studies described in this paper. 
PQQ is of interest for several reasons. It is a tricyclic, redox active o-quinone that is 
not formed by direct post-translational modification of active site residues, but instead is 
synthesized by way of a RiPP pathway.15, 44, 72 PQQ is a significant antioxidant, and when 
present supports mitochondrial biogenesis and function in a wide range of organisms.24-30 
Additionally, PQQ demonstrates probiotic properties in mammals; studies with rats and 
mice have demonstrated decreased growth, reduced immune response, and declining 
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reproductive success when subjects were deprived of PQQ in their diets.19-22 While 
initially considered a cofactor for prokaryotes only, a recent publication identified a 
fungal enzyme for which PQQ serves as cofactor.18 Finally, plant studies indicate that the 
presence of PQQ promotes growth.73 
Only one structural model of PqqD has been published, and this is a dimeric crystal 
structure of Xanthomonas campestris (Xc) PqqD (PDB ID: 3G2B).63 However, the 
physiological state of PqqD is monomeric,44 so the biological relevance of the XcPqqD 
structure is uncertain. In this study, the PqqD portion of the natural Methylobacterium 
extorquens fusion PqqCD was expressed in Escherichia coli to give 13C and 15N 
isotopically labeled protein, which was purified and subjected to NMR spectroscopic 
analysis. The interaction of the isotopically labeled MePqqD with unlabeled and 
chemically synthesized MePqqA, which binds with a Kd of ~ 200 nM,44 was also probed 
by NMR spectroscopy. Here we present the MePqqD resonance and secondary structure 
assignments in the absence and presence of MePqqA in the pursuit of the physiological 
structure of PqqD and the mapping of the interaction surface of PqqA on PqqD. 
Experimental Procedures (Methods and experiments) 
Recombinant protein expression and purification 
Materials - The T4 DNA ligase and restriction enzymes were obtained from New 
England BioLabs (Ipswich, MA). Polymerase was obtained from Agilent Technologies 
(Santa Clara, CA). Oligonucleotides were obtained from Eurofins (Huntsville, AL). All 
DNA sequencing was performed by the University of California’s DNA Sequencing 
Facility (Berkeley, CA). 
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Preparation of PqqA - The unlabeled peptide, MePqqA ΔΜ1, C12S (derived from the 
wild type, UniProt # Q49148), was synthesized and purified to >80% purity by CPC 
Scientific (Emeryville, CA) and then used at that purity. The peptide sequence, 
KWAAPIVSEISVGMEVTSYESAEIDTFN, incorporated a serine in place of the 
cysteine at residue position 11 to eliminate spurious dimer formation. 
Preparation of 15N- and 13C-labeled, recombinant PqqD - The MepqqD gene 
(corresponding to amino acids 280-372 from the natural MePqqCD fusion) was cloned 
into the pET28a vector (EMD Millipore) using the NdeI and XhoI restriction sites.  The 
cloned gene, incorporating an N-terminal His6-tag, was sequence verified and used to 
transform E. coli BL21 (DE3) for gene expression. Transformed E. coli BL21 (DE3) cells 
were grown aerobically at 37 ºC in M9 minimal media supplemented with 1 g/L NH4Cl 
(99% 15N, Cambridge Isotopes, Tewksbury, MA), 4 g/L D-glucose (U-13C, Cambridge 
Isotope Laboratories, Tewksbury, MA) and 50 µg/mL kanamycin. Cells were induced 
with 1 mM IPTG when the OD600 reached 0.6. Following a 12 h induction at 20 ºC, the 
cells were harvested by centrifugation at 6,500 rpm for 10 min. The cells were suspended 
in five times the mass of cell paste of 50 mM PBS (pH 7.5) and 50 mM imidazole. The 
cells were lysed by sonication, and the lysate was centrifuged at 20,000 rpm for 15 min.  
The supernatant was loaded onto a 5 mL HisTrap FF column (GE Healthcare) and the 
column was washed at 4 ºC with lysis buffer to remove non-tagged protein, and then with 
50 mM PBS (pH 6.5) and 300 mM imidazole to elute the tagged protein. The desired 
fractions were combined, concentrated, and buffer exchanged over PD-10 columns (GE 
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Healthcare) equilibrated with 25 mM phosphate buffer (pH 6.5). Yield for His6-tagged 
13C-,15N-labeled MePqqD: 27 mg/L culture. 
Experimental quantities 
NMR experiments were performed using D2O matched Shigemi microtubes, 5 mm 
O.D. (Shigemi, Inc.). The experimental solution for PqqD alone contained 285 µL of 5.0 
mg/ml (0.40 mM) 13C-,15N-labeled MePqqD in 25 mM potassium phosphate, pH 6.5, 7 
µL of 50 mM sodium azide, and 15 µL HPLC grade D2O (final concentrations: 4.6 mg/ml 
(0.37 mM) MexPqqD, 1.1 mM sodium azide, 4.9% D2O). 
The experimental solution for PqqD bound to PqqA (in approximately 4-fold molar 
excess) was identical to the PqqD alone with the inclusion of 1.35 mg lyophilized, 
unlabeled MePqqA (final concentrations: 4.6 mg/ml (0.37 mM) MePqqD, 4.4 mg/ml 
MePqqA (1.4 mM), 1.1 mM sodium azide, 4.9% D2O). 
NMR spectroscopy 
Instrumentation and conditions - All NMR data were recorded at 25°C on Bruker 
AVANCE™ III 850 or 900 MHz NMR spectrometers, each with 5 mm TCI CryoProbes 
including shielded z-gradient. Two sets of NMR data were acquired with the two 
samples, 13C-,15N-labeled PqqD and 13C-,15N-labeled PqqD + unlabeled PqqA. The tight 
binding of PqqD and PqqA precluded a titration approach. Data were processed with 
nmrPipe.74 Proton chemical shifts were calibrated with respect to the water signal relative 
to DSS ((CH3)3Si(CH2)3SO3Na); 15N and 13C chemical shifts were indirectly referenced 
to DSS.75 Linear predictions were applied to the 15N and 13C dimensions to double the 
data size and improve digital resolution. A cosine square window function and “auto” 
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zero filling were applied to all 1H, 15N and 13C dimensions. Data were analyzed with 
Sparky.76 
Experiments - Sequence-specific backbone assignments were completed using 
AutoAssign with two 3D spectra: HNCACB and CBCA(CO)NH.77, 78 The HNCACB 
creates both intra- and inter-residue correlations, whereas the CBCA(CO)NH creates only 
inter-residue correlations. Combining these two spectra, backbone chemical shifts, 
including 1HN, 15N, 13CA, 13CB, were assigned. 13C¢ chemical shifts were assigned using 
a 3D HNCO and the first 2D 1H-13C plane of 3D HNCACO.79   1H and 13C side chain 
assignments were performed with HCCH-TOCSY, H(CCCO)NH and C(CCO)NH 
(mixing time: 16 ms).80, 81 HA assignments and scalar J coupling 3JHNHA were obtained 
from 3D HNHA spectrum.82 The 1Hd and 1He resonances of aromatic residues were 
assigned using 2D (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE.83 
Results (Assignments and data deposition) 
Backbone and sidechain 1H, 15N, and 13C chemical shifts were assigned at 100% with 
the exception of 14 of 27 aromatic 13C’s (52%) and 4 of 21 aromatic 1H’s (19%), which 
were not assigned. A superposition of the 2D 1H-15N HSQC spectra for PqqD (blue 
peaks) and PqqD + PqqA (red peaks) is shown (Figure 15). From this plot, changes in the 
chemical shifts of 1H and 15N could clearly be identified. The complete backbone and 
side chain chemical shift assignments have been deposited in the BioMagResBank 
database (www.bmrb.wisc.edu) with accession numbers 26634 and 26690 for samples 
PqqD and PqqD + PqqA, respectively. 
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Figure 15. Overlay of 2D 1H-15N HSQC spectra for 13C-,15N-labeled MePqqD (blue) 
and 13C-,15N-labeled MePqqD + unlabeled MePqqA (red) showing peak shifts. 
 
Discussion (Secondary structure information) 
The chemical shifts of 1Ha, 13Ca, 13Cb and 13CO resonances were used as an input to 
TALOS+ and CSI2.0 to predict the secondary structures of the two samples.84, 85 The 
secondary structures predicted from the two methods for PqqD in each sample are very 
similar (Figure 16). The main difference observed between the two samples, PqqD and 
PqqD + PqqA, is that one b-strand from the sequence fragment RTFDL of PqqD is 
significantly longer in the presence of PqqA. In addition, the order parameters predicted 
by TALOS+ and the flexibility predicted by CSI2.0 are consistent between each sample. 
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Besides the N-terminus of PqqD (residues 1 and 8), the region between residues 51 and 
56 in both samples indicates high mobility and disorder. 
 
Figure 16. Secondary structures predicted by TALOS+ and CSI2.0 for MexPqqD 
(the first two rows) and MexPqqD + MexPqqA (the last two rows). The MexPqqD 
sequence is shown above the secondary structure predictions with sequence decades 
indicated. Arrows and helices represent β-strand and α-helices, respectively. 
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CHAPTER 3 
 
This chapter (with supplemental material reintegrated) is reprinted with permission from 
American Chemical Society Biochemistry. 
Biochemistry, 2017, 56, pp 2735–2746 DOI: 10.1021/acs.biochem.7b00247 
Copyright © 2017 American Chemical Society  
 
NMR structure and binding studies of PqqD, a chaperone required in the 
biosynthesis of the bacterial dehydrogenase cofactor pyrroloquinoline quinone 
Robert L. Evans III, John A. Latham, Youlin Xia, Judith P. Klinman, Carrie M. Wilmot 
 
Paper 2 Abstract 
Biosynthesis of the ribosomally synthesized and post-translationally modified peptide 
(RiPP), pyrroloquinoline quinone (PQQ), is initiated when substrate peptide, PqqA, is 
recognized and bound by the RiPP precursor peptide recognition element (RRE), PqqD, 
for presentation to the first enzyme in the pathway, PqqE. Unlike other RiPP-producing, 
post-ribosomal peptide synthesis (PRPS) pathways in which the RRE is a component 
domain of the first enzyme, PqqD is predominantly a separate scaffolding protein that 
forms a ternary complex with the precursor peptide and first tailoring enzyme. As PqqD 
is a stable, independent RRE, this makes the PQQ pathway an ideal PRPS model system 
for probing RRE interactions using nuclear magnetic resonance (NMR). Herein, we 
present both the solution NMR structure of Methylobacterium extorquens PqqD, and 
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results of 1H,15N-HSQC binding experiments that identify the PqqD residues involved in 
binding the precursor peptide, PqqA, and the enzyme, PqqE. The reported structural 
model for an independent RRE, along with the mapped binding surfaces, will inform 
future efforts to both understand and to manipulate PRPS pathways. 
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Introduction 
RiPPs comprise a collection of diverse natural products with probiotic as well as 
antibiotic, anti-cancer, and anti-viral activities.23, 86-88 Recent genome sequencing efforts 
have demonstrated that RiPPs represent a major natural product biosynthesis route in 
addition to terpenoid, alkaloid, polyketide, and non-ribosomal peptide (NRP) 
biosyntheses.11 In NRP biosynthesis, peptide bond formation requires multimodular 
“megaenzymes” in an assembly line encoded within the operon.11, 34, 88 In comparison, 
PRPS pathways can produce equally complex and diverse molecules from simpler 
operons, as they utilize ribosomal machinery to produce the precursor peptide that is 
subsequently modified. RiPPs can encompass ≥70 amino acids, such as the putative pore-
forming bacteriocin, enterocin AS-48, for which an X-ray crystal structure exists,89 or be 
relatively small, as with the 330 Da tricyclic o-quinone, PQQ (C14H6N2O8, 4,5-dihydro-
4,5-dioxo-1H-pyrrolo[2,3-f] quinolone-2,7,9-tricarboxylic acid) derived from two amino 
acid residues (Figure 17).90, 91 PQQ biosynthesis is part of a PRPS biosynthesis subclass 
that includes pantocin, mycofactocin, and thyroid hormone biosyntheses.11, 53, 92 
 
Figure 17. Chemical structure of PQQ. All of the carbons and nitrogens in PQQ 
come from a glutamate and tyrosine in an absolutely conserved EXXXY sequence 
located in the precursor peptide, PqqA.  Atoms and bonds colored red are derived 
from the glutamate, and those colored blue are from the tyrosine.  Black represents 
modifications during biosynthesis. 
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PQQ is the cofactor for a class of bacterial aldose sugar and alcohol 
dehydrogenases.14-17 The cofactor is synthesized outside of the dehydrogenase framework 
and then non-covalently inserted into the apoenzyme.4-6 These dehydrogenases, and 
therefore PQQ, give a growth advantage to the bacteria when aldose sugars and/or 
alcohols are available.93 The electrons generated by the reduction of PQQ to PQQH2 are 
fed into the constitutive electron transport chain of the organism and ultimately generate 
ATP. More recently, data suggested that PQQ may be a sugar oxidoreductase coenzyme 
in the basidiomycete mushroom, Coprinopsis cinerea.18 
The majority of PQQ-producing bacteria are Gram-negative, and include a number of 
human pathogens, such as Klebsiella pneumoniae and Burkholderia cenocepacia.12 
Interestingly, PQQ also enhances the growth rate of some non-PQQ-producing bacteria, 
such as Escherichia coli, which under certain nutrient conditions express a PQQ-
dependent dehydrogenase.6, 94 Therefore, PQQ is a prokaryotic vitamin. 
Eukaryotes do not synthesis PQQ; however, removal of PQQ from the diets of mice 
and rats leads to decreased fertility, smaller litter sizes, and slowed neonatal growth.19-22 
The specific mechanism(s) by which PQQ alters reproductive success is currently 
unknown, although data that show PQQ promotes mitochondrial metabolism are 
emerging.24-30 As an antioxidant, PQQ can undergo approximately 20,000 redox cycles, 
making it, on a molar basis, 100 times more efficient than ascorbic acid as a cellular 
redox molecule.31-33 
While biochemically intriguing in its own right, the PQQ biosynthesis pathway 
contains an independent RRE protein that can serve as a model system for understanding 
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the presentation of precursor peptides by enzyme-integrated RRE domains, which are 
present in > 50% of all PRPS pathways.11, 42 PQQ biosynthesis requires five or six genes 
encoded by the pqq operon; pqqA–E are absolutely required, while an additional gene for 
a putative protease, pqqF, is also often present.2, 12 PQQ biosynthesis is initiated when the 
precursor peptide, PqqA, is recognized and bound by PqqD for presentation to the first 
tailoring enzyme, PqqE, a member of the radical S-adenosyl methionine (rSAM) 
superfamily of enzymes that additionally contain a C-terminal subtilosin, PQQ, anaerobic 
sulphatase, and mycofactocin (SPASM) domain.2 PqqD is a member of the structurally 
conserved RREs but is unusual in being a stand-alone peptide chaperone, as most RREs 
are domains within PRPS biosynthesis enzymes.42, 95 The core segment of PqqA contains 
an absolutely conserved EXXXY sequence, in which the glutamate and tyrosine residues 
contain all the carbons and nitrogens comprising PQQ (Figure 17).96, 97 
This paper presents the nuclear magnetic resonance (NMR) solution structure for 
Methylobacterium extorquens (Me) PqqD, which represents the first experimental 
structure of PqqD in its physiological monomeric form. Further, we identify the residues 
of PqqD involved in binding PqqA alone, and in binding PqqE within the ternary 
complex. These findings are placed in the context of other structural work on RRE 
domain interactions with RiPP precursor peptides and the enzymes of which they are a 
part. 
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Experimental Procedures 
Materials 
The T4 DNA ligase and all restriction enzymes were purchased from New England 
BioLabs (Ipswich, MA). Oligonucleotides were purchased from Eurofins (Huntsville, 
AL). Polymerase was obtained from Agilent (Santa Clara, CA). DNA sequencing was 
performed by the University of California DNA Sequencing Facility (Berkeley, CA). The 
precursor peptide, MePqqA (Uniprot entry Q49148), was chemically synthesized and 
purified (80% purity) by CPC Scientific (Emeryville, CA) and used without further 
purification in experiments. The MePqqA peptide used in these studies did not include 
the N-terminal methionine, and residue 11 was changed from a cysteine to a serine to 
avoid interpeptide crosslinking. The final sequence for the construct was 
KWAAPIVSEISVGMEVTSYESAEIDTFN (the absolutely conserved EXXXY sequence is 
highlighted). 
Recombinant expression of 13C, 15N-labeled PqqD 
Although PqqD predominantly exists as a separate protein in most PQQ biosynthesis 
pathways, MePqqD is found N-terminally fused to MePqqC. A truncation of MePqqCD 
(Uniprot entry Q49150) containing only the MePqqD portion was constructed, which had 
been done in previous studies in which the presence of the MePqqC portion of the native 
polypeptide was shown to have no effect on the binding of MePqqA and MePqqE to 
MePqqD.44 The truncation sequence was derived by aligning the MePqqCD natural 
fusion sequence with PqqD and PqqDE sequences from 8 other bacterial species: 
Pseudomonas putida, Acinetobacter calcoaceticus, Klebsiella pneumoniae, Azotobacter 
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vinelandii, Gluconobacter oxydans, Rhodopseudomonas palustris, Methylocystis sp. 
(containing the natural fusion, PqqDE), and Xanthomonas campestris (XcPqqD)(Clustal 
Omega, www.ebi.ac.uk/Tools/msa/clustalo/).98-100 The 94 residues comprising the 
MePqqD used in the study include an N-terminal methionine followed by 5 residues 
(EPTAF) representing the juncture of the linker and PqqD protein and the remaining C-
terminal residues from MePqqCD. Thus, the MePqqD sequence is: 
MEPTAFSGSDVPRLPRGVRLRFDEVRNKHVLLAPERTFDLDDNAVAVLKLVDGRNTV
SQIAQILGQTYDADPAIIEADILPMLAGLAQKRVLER (Figure 18). 
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Figure 18. The PqqD portion of MePqqCD was identified using an alignment of 9 
species, 2 of which were natural fusions. ‘MexCD_(Q49150)’ represents MePqqCD. 
The pink/purple arrow identifies the linker region and PqqC enzyme portion of the 
fusion, and the purple/blue, PqqD. The Uniprot identifiers are enclosed in 
parentheses and the alignment was completed using Clustal Omega 
(http://www.uniprot.org/ and http://www.ebi.ac.uk/Tools/msa/clustalo/, 
respectively). 
 
The truncated MepqqD gene construct was cloned into a kanamycin resistant pET28a 
vector with an N-terminal His6-tag (EMD Millipore). The gene was used to transform E. 
coli BL21 (DE3) cells for gene expression. Cells were grown aerobically in minimal 
media supplemented with 13C- and 15N-labeled ammonium chloride and D-glucose, 
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respectively (Cambridge Isotope Laboratories, Tewksbury, MA). The yield for the His6-
tagged, 13C-,15N-labeled MePqqD was 27 mgs per liter of culture. After immobilized 
metal affinity chromatography purification (nickel column), the protein was buffer 
exchanged into 25 mM potassium phosphate (pH 6.5) for all NMR experiments. For 
experiments involving the ternary complex only, the PqqD sample had been lyophilized 
for storage. 
Recombinant expression of unlabeled PqqE 
The gene encoding MePqqE (UniProt entry P71517) was cloned into the pET28a 
vector from genomic DNA using the NdeI and XhoI restriction sites. After sequence 
verification, the cloned gene was used to transform E. coli BL21(DE3) that also 
contained a suf operon plasmid, pPH149, for gene expression. The pPH149 and 
pqqE/pET28a-transformed cells were grown aerobically at 37 °C in TB media containing 
35 g/ml chloramphenicol and 50 g/ml kanamycin. At a cell density of A600 = 0.6, 50 µM 
iron(III) citrate and 5 mM fumarate were added. The growth flasks were immediately 
stoppered so that the transition to anaerobic conditions occurred. Anaerobic growth was 
allowed to continue for 30 minutes at 37 °C, after which the expression of His6-MePqqE 
was induced by adding 0.4 mM isopropyl-D-galactopyranoside. Following a 12-hour 
induction period at 19 °C, cells were centrifuged for 10 minutes at 6,500 rpm and then 
frozen. Subsequent work was performed in an anaerobic chamber. Cells were suspended 
in 5x (mass of cell paste) degassed 50 mM Tris buffer (pH 7.9), 50 mM imidazole, 1 mM 
TCEP, and 200 mM sodium chloride (lysis buffer). Cells were lysed following the 
manufacturer’s protocol for BugBuster (Novagen). BugBuster was supplemented with 
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Benzonase (Novagen). Lysate was transferred into sealed tubes for centrifugation 
(outside the anaerobic chamber) for 15 minutes at 20,000 rpm. The sealed tubes were 
then moved back into the anaerobic chamber where the combined supernatants were 
loaded onto a 5 ml His-Trap FF column (GE Healthcare) using a peristaltic pump. The 
column, maintained at 22 ºC, was washed first with lysis buffer to remove non-tagged 
protein and then with a degassed solution consisting of 300 mM imidazole, 50 mM Tris 
(pH 7.9), 1 mM TCEP, and 200 mM sodium chloride to elute the tagged protein. 
Fractions were combined, concentrated, and buffer exchanged using PD-10 columns 
equilibrated with degassed 50 mM Tris (pH 7.9), 100 mM sodium chloride, 5% glycerol, 
and 1 mM TCEP. The protein, anaerobically aliquoted and sealed in cryogenic vials, was 
then flash frozen in liquid nitrogen. Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis was used to confirm protein homogeneity. The yield of His6-MePqqE was 
18 mgs per liter of culture. 
NMR Experiments 
The PqqD protein was highly stable, and periodic 1H,15N-HSQCs on the single 
sample used for all experiments showed no discernable degradation over the multiple 
months of data collection. Likewise, the varying PqqD:PqqA and PqqD:PqqA:PqqE 
ratios were highly stable, and a single preparation of each of these also lasted for the 
duration of the experiments needed for structure determination and binding studies. 
Protein samples were stored at 4 ºC when not in use. 
All NMR experiments were performed using D2O matched 5 mm Shigemi 
microtubes. The PqqD sample contained 0.14 mM MePqqD, 1.0 mM sodium azide, and 
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5% D2O. The physiological stoichiometry for PqqD with PqqA is 1:1, with a dissociation 
constant (KD) of ~200 nM for the MePqqA-PqqD complex.44 To determine the proper 
molar ratio of PqqD and PqqA for defining the residues of PqqD affected by binding 
PqqA, three two dimensional (2D) 1H,15N-HSQC spectra were acquired at PqqD:PqqA 
ratios of 1:0, 1:0.7, and 1:1.3. The 2D HSQC spectra demonstrated that at a PqqD:PqqA 
ratio of 1:1.3, all chemical shift changes were complete with peaks fully evolved. The 
PqqD–PqqA samples were made by adding 0, 5, and 10 µL of 6.4 mM PqqA, in identical 
buffer, to the 270 µL PqqD only sample (for the 1:0, 1:0.7, and 1:1.3 sample ratios, 
respectively). The starting concentration of PqqD was 0.17 mM in the presence of 1.0 
mM sodium azide, and 5% D2O. 
The physiological stoichiometry for PqqA with PqqE and PqqD is 1:1:1, with KD 
values of ~12 µM for the MePqqD–PqqE binary complex and ~5 µM for the MePqqD–
PqqA–PqqE ternary complex.44 Protein solubility was an issue with the PqqD–PqqA–
PqqE sample, as PqqE tended to precipitate out of solution as the ratio of PqqE to PqqD 
exceeded 0.2 to 1. However, chemical shift assignments for the identification of PqqD 
residues involved in binding PqqE in the presence of PqqA could be ascertained using a 
1:1.25:0.2 PqqD:PqqA:PqqE ratio. Therefore, the volume of the PqqD–PqqA–PqqE 
sample was made to be similar to those of the other samples but contained 0.80 mM 
MePqqD (~ six times the quantity used in the previous experiments in order to increase 
signal-to-noise due to the weak NMR signal of the slower tumbling ternary complex), 1 
mM MePqqA (25% excess over PqqD), 0.16 mM MePqqE (only 20% of PqqD), 1.0 mM 
sodium azide, and 5% D2O. The PqqE was diamagnetic as the samples were treated 
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aerobically throughout all experiments, as was done in the previously published work that 
determined KD values.44 
All experiments were performed at 25 °C on Bruker 850 or 900 MHz spectrometers, 
each equipped with 5 mm TCI CryoProbes. NMRPipe74 was used to process 
experimental data. Proton chemical shifts were calibrated with respect to the water signal 
relative to 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), and 13C and 15N chemical 
shifts were indirectly referenced to DSS.101 Data were analyzed leading to peak 
assignments using Sparky.76 The complete backbone and side chain chemical shift 
assignments for MePqqD have been deposited in the BioMagResBank 
(BMRB)(www.bmrb.wisc.edu) with accession numbers 26634 for PqqD only, 26690 for 
the PqqD–PqqA complex, and 26696 for the PqqD–PqqA–PqqE ternary complex.102, 103 
Binding studies (PqqD and PqqA) 
As for chemical shift assignments, NMR data acquired from PqqD and PqqA were 
similar to those of PqqD alone. Typically, sequence-specific backbone assignments were 
completed using two three dimensional (3D) spectra, IBS_Best_HNCACB and 
IBS_Best_HN(CO)CACB.104 The IBS_Best_HNCACB experiment reveals both intra- 
and inter-residue correlations, whereas the IBS_Best_HN(CO)CACB experiment reveals 
inter-residue correlations. The IBS_Best version of the two experiments improves signal 
sensitivity. Via combination of these two spectra, backbone chemical shifts, including 
1HN, 15N, 13CA, and 13CB were assigned.102 The assigned 1HN and 15N shifts were then 
used to identify PqqD residues involved in the binding of PqqA. Data sets acquired from 
experiments using both PqqD alone and PqqD–PqqA samples were used to assign 13C¢ 
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and sidechain chemical shifts.102 Complete chemical shift assignments were obtained for 
both samples. Finally, an overlay of the 1H,15N-HSQC spectra for PqqD alone and PqqD 
with PqqA identified residues for which the weighted peak shifts (Equation 1)105 were at 
least 1.5 standard deviations from the statistical mean for all shifts, thus indicating which 
of the RRE residues are involved in binding the precursor peptide. 
 (1) 
Binding studies (PqqD–PqqA–PqqE) 
A comparison of the 2D 1H,15N-HSQC spectra acquired for PqqD, PqqD–PqqA, and 
PqqD–PqqA–PqqE samples showed that the changes in chemical shifts for spectra from 
the binary complex to the ternary complex were not as significant as those from PqqD 
alone and PqqD with PqqA. It was not, therefore, necessary to acquire a full set of NMR 
data to assign the chemical shifts of PqqD in the ternary complex as it was for PqqD with 
PqqA. We were able to use the assigned chemical shifts of PqqD in the binary complex 
and limited NMR data for the PqqD–PqqA–PqqE sample to assign the backbone 
chemical shifts of PqqD in the ternary complex. These data included a 3D 
IBS_Best_HNCA, a 3D HNCO, and the first 1H-13C 2D plane of an HN(CA)CO, 
allowing for the assignment of chemical shifts for backbone HN, N, CA, and CO 
atoms.104 No experiments that aimed to assign sidechain chemical shifts were performed. 
A 2D 1H,15N-HSQC spectrum using the IBS_SOFAST pulse sequence was also 
acquired.106 The IBS_SOFAST pulse sequence enhanced signal sensitivity to about three 
times that of a regular HSQC and allowed for the acquisition of a 2D HSQC spectrum 
with high sensitivity in just 20 minutes. Again, an overlay of the 1H,15N-HSQC spectra 
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for PqqD alone versus that of the PqqD–PqqA–PqqE sample identified residues for which 
the weighted peak shifts were at least 1.5 standard deviations from the mean for all shifts, 
indicating RRE residues involved in binding the initial tailoring enzyme, PqqE, during 
peptide presentation. 
3D structure determination 
To determine the 3D structure of MePqqD, we utilized internuclear distances from 
NOE spectra, dihedral angles estimated from the chemical shifts using TALOS+, scalar 
3JHNHA coupling constants from HNHA spectrum, and hydrogen bonds (Table 3).84, 107 
Even though the only deposited structure for PqqD [XcPqqD, Protein Data Bank (PDB) 
entry 3G2B] is a non-physiological dimer in which β-hairpins are exchanged between 
monomers, an in silico PqqD monomer model was created using PyMOL by combining 
the β-hairpin from one monomer with the α-helical bundle of the other (Figure 19).63 
 
Figure 19. The PqqD structure. (A) The MePqqD monomeric NMR solution 
structure. (B) The XcPqqD dimeric crystal structure showing that the domain 
swapped β-hairpins occupy a similar position in the MePqqD monomer. 
 
This model had a fold similar to the RRE domains of PRPS biosynthesis enzyme crystal 
structures and was used to inform NOE peak assignments. The intensities of NOE cross 
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peaks of two 3D 15N- and 13C-edited NOESY spectra were binned into three categories: 
strong, medium, and weak, corresponding to 1.8–3.7, 1.8–5.0, and 1.8–6.0 Å distance 
restraints, respectively. A total of 2,697 NOE-derived distances were obtained from the 
NMR spectra and converted into unambiguous structural restraints. On average, we 
obtained 28.7 unique distance restraints per residue. The chemical shifts for the 1Ha, 13Ca, 
13Cb, and 13CO resonances were used as an input for TALOS+ to predict backbone 
dihedral angles f and y. A total of 158 f and y  angle restraints were implemented in the 
structure calculation protocol. Three-bond scalar 3JHNHA coupling constants were 
obtained from the 3D HNHA experiment using the equation 
J = [(-Scross/Sdiagonal)/(2pd)]1/2, where Scross and Sdiagonal are the signal intensities of cross 
and diagonal peaks, respectively, and d (= 0.013 s) is the time delay used in this 
experiment.107 A total of 82 3JHNHA coupling constants were entered into the structure 
calculation protocol. 
Structure calculations were performed using XPLOR-NIH version 2.37.108, 109 As a 
starting structure, an extended conformation of the polypeptide with randomized dihedral 
angles was used. Torsion angle restrained molecular dynamics (rMD) was performed at 
3,500 K for 100 ps. Subsequently, hybrid simulated annealing and rMD calculations were 
performed. After several rounds of structure calculations, the conformers converged to a 
similar fold with an ~1 Å root mean square deviation (RMSD) for all heavy atoms. At 
this stage, 15 hydrogen bonds between the carbonyl and the amide groups of the 
backbone in the α-helices and between β-strands were identified using two criteria: 
donor-acceptor distances of < 2.4 Å and angles of < 35°. Therefore, a total of 30 
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hydrogen bond restraints (each hydrogen bond having two distance restraints) were 
included in the final stage of energy minimization. One hundred conformers were 
calculated, and the 20 best structures were chosen for the final analysis. During structural 
refinement, calculated structures and constraints were validated using the Protein 
Structure Validation Suite (PSVS) (http://psvs-1_5-dev.nesg.org/). The average RMSDs 
for all atoms and for just the α-carbons were obtained using the PyMol "super" command 
(allowing 5 outlier rejection cycles).110 The calculations were performed using the lowest 
energy MePqqD model’s core fold (residues 17–90) and the XcPqqD in silico model’s 
core fold (defined as residues 15–31 from one monomer and residues 34–88 from the 
second)(Figure 19). The NMR solution structure for MePqqD, based on BMRB entry 
26634, has been deposited as PDB entry 5SXY.111, 112 Figures containing images of 
protein structures were created using MacPyMOL,113 and NMR HSQC spectra were 
generated using Sparky.76 
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Table 3. Structural statistics for 20 model ensemble 
 
Results 
Structure of M. extorquens PqqD 
This structure represents the first detailed physiological structure of PqqD in its 
monomeric solution state.44, 63, 114 The restraints used in the structure determination and a 
comparison of the 20 lowest-energy structures are given in Table 2. Labeled PqqD 
showed an excellent 1H,15N-HSQC signal-to-noise ratio with clear peak separation even 
in the most peak-dense regions of the spectra (Figure 20). All backbone and sidechain 1H, 
15N, and 13C chemical shifts were assigned with the exception of 14 (of 27) aromatic 13C 
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atoms and 4 (of 21) aromatic 1H atoms, because of the inherent ambiguity of C-H 
definition within an aromatic ring.102 On the basis of 1Ha, 13Ca, 13Cb, and 13CO chemical 
shift resonances, PqqD was predicted to contain three β-strands and three α-helices, and 
the top 20 (lowest-energy) annealed structures display a common core containing 
precisely these elements (Figure 21). 
 
Figure 20. (A) 1H,15N-HSQC of PqqD alone (blue peaks) overlaid with the 1H,15N-
HSQC of PqqD in complex with PqqA (red peaks). (B) 1H,15N-HSQC of PqqD in the 
binary complex with PqqA (red peaks) overlaid with that of PqqD in the ternary 
complex with PqqA + PqqE (green peaks). (C) Expanded section from panel A 
showing peak separation. (D) Expanded section from panel B showing peak 
separation. 
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Figure 21. NMR structure of MePqqD. (A) Topology and location of secondary 
structure vs primary sequence as predicted by TALOS+ (a) and CSI2.0 (b). (B) Cα 
trace of the superposition of the 20 lowest energy NMR conformers. (C) Cartoon of 
the lowest energy conformer. α-helices, red; β-strands, yellow; loops, green. 
 
All residues in the ensemble (20 x 94) were in favored or allowed Ramachandran 
regions with no residues in disallowed regions. The PqqD structural order predicted by 
TALOS+84 and CSI2.085, 115 indicated a high level of disorder at the N-terminus [residues 
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1–7, (Figure 22)]. 
 
Figure 22. Structural order and flexibility by residue number as predicted by 
TALOS+ (A) and CSI2.0 (B). 
 
This is perhaps not surprising as the PqqD construct used in this study was derived from 
the natural MePqqCD fusion, so the N-terminus in the native protein is connected to the 
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C-terminus of PqqC via a 26-residue polypeptide linker (Figure 23). 
 
Figure 23. The linker region in MePqqCD was identified using an alignment of 
MePqqCD and Klebsiella pneumoniae PqqC and D. 
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There is no evidence that PqqC and PqqD specifically interact, so MePqqD can be 
viewed as “tethered” and independent of MePqqC. 
PqqD residues involved in binding PqqA 
PqqA must be bound to PqqD to become a substrate for the first enzyme in PQQ 
biosynthesis, PqqE.45 To map the binding site, NMR was used to define the PqqD 
residues with which PqqA interacts. 2D HSQC spectra demonstrated that at a 
PqqD:PqqA ratio of 1:0.7 (Figure 24B), the chemical shifts observed were in positions 
identical to those for PqqD alone (Figure 24A) and PqqD fully bound to PqqA (Figure 
24C). This indicates slow chemical exchange relative to the NMR time scale and is 
consistent with the reported KD of ~200 nM.44 As such, an HSQC titration experiment to 
track migrating peaks was not possible, and all chemical shifts for the PqqD–PqqA 
sample had to be completely reassigned. 
 
Figure 24. (A) .1H,15N-HSQC for PqqD alone. (B) An overlay of the spectra before 
saturation at a PqqD:PqqA ratio of 1:0.7. (C) The fully evolved spectrum indicating 
saturation at a ratio of 1:1.3. 
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An examination of the weighted (Equation 1) 1H,15N-HSQC peak shifts ≥ 1.5σ above 
the mean shift between the unbound and binary complex spectra identified the following 
PqqD residues as being involved (either directly or indirectly) in binding PqqA: Phe38*, 
Asp39*, Asp41*, Asp42*, Asn43*, Ala44*, Val45, Val47, Leu48, and Val91 (asterisks 
indicate residues ≥ 2σ above the mean shift). These residues are almost contiguous in the 
primary sequence (38–48), except for residue 91, and those ≥ 2σ above the mean shift are 
located in the third β-strand (β3) and first α-helix (α1) (Figure 21C) that together form a 
“saddle” in the structure between the β-sheet and the α-helical bundle (purple, Fig. 25). 
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Figure 25. PqqD residues identified as having 1H,15N-HSQC peak shifts ≥ 1.5σ above 
the mean shift are indicated for the complex with PqqA (purple) along with 
additional residue peak shifts upon addition of PqqE to the PqqD + PqqA complex 
(green). Ternary complex interactions are based on chemical shifts of the backbone 
only, however sidechains are displayed for recognition ease. PqqD cartoon and 
molecular surface renderings from the same viewpoint are shown in each panel, 
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Additional PqqD residues perturbed when PqqE binds the PqqD–PqqA binary complex  
For the rSAM enzyme, PqqE, to act on the precursor peptide, PqqA, it must be bound 
to PqqD.45 PqqE is the first enzyme in PQQ biosynthesis, and it catalyzes the formation 
of a carbon–carbon cross-link between the Tyr and Glu of PqqA, the residues that 
provide most of the raw material for PQQ (Figure 17).45, 114 Although MePqqE can form 
a binary complex with MePqqD in the absence of MePqqA (KD ~ 12 µM), it is the ternary 
complex (PqqD–PqqA–PqqE) that is physiologically relevant.44, 45, 114 Therefore, NMR 
was used to define additional residues on PqqD that were involved in binding PqqE 
within the context of the ternary complex. PqqE is large compared to PqqD and PqqA 
(MePqqE, 41.7 kDa; MePqqD, 10.4 kDa; MePqqA, 3.07 kDa), so the ternary complex 
tumbles significantly more slowly than PqqD–PqqA. To overcome the resulting weaker 
signal-to-noise ratio, the concentration of PqqD was increased, but this led to PqqE 
precipitating out of solution at ratios greater than 20% PqqD. Therefore, while binding of 
PqqE to the PqqD–PqqA complex was within the regime where an NMR titration 
experiment could be possible (KD ~5 µM), it was impractical.44 Even though PqqD, 
PqqA, and PqqE bind in a 1:1:1 ratio, PqqE at 20% of the concentration of PqqD was 
sufficient to visualize HSQC peak shifts (Figures 20B, D). Reassignment of the chemical 
shifts was performed for backbone atoms only. 
1H,15N-HSQC peak shifts ≥ 1.5σ above the mean shift between the binary complex 
and ternary complex spectra indicated that the additional PqqD residues involved in 
binding PqqE in the presence of PqqA are: Ser9*, Leu20, Leu31*, Ala33*, Leu40, 
Asp71, and Arg94* (asterisks indicate residues ≥ 2σ above the mean shift) (green, Fig. 
  64 
25). The two most N-terminal β-strands and residues in the N-terminal and C-terminal 
tails of the polypeptide are interacting (directly or indirectly) with PqqE. Interestingly, 
Leu40, which showed no peak shift in the PqqD–PqqA complex but lies between the β-
strand and α-helix to which PqqA binds, now becomes perturbed in the ternary complex 
(green, Fig. 25). Whether this is a direct interaction, or an indirect effect mediated 
through PqqA, is currently unknown. 
Discussion 
The monomeric NMR structure of MePqqD represents the first detailed, physiologically 
relevant structure of PqqD 
Size exclusion chromatography, along with small angle x-ray scattering (SAXS) 
experiments, and now NMR show that PqqD is physiologically monomeric.44, 114 The 
MePqqD NMR solution structure closely resembles the in silico models created to model 
the SAXS data and to show that PqqD likely belongs to the “prevalent peptide-binding 
fold” in PRPS biosynthesis pathways.42, 44 These in silico models, and the model used to 
assist with NOE peak assignments, were informed by an earlier x-ray structure (PDB 
entry 3G2B) showing the protein as a dimer.63 The XcPqqD dimerization observed in the 
structure was likely due to the high protein concentration required for crystallization.63 
While the secondary structure is largely intact in the XcPqqD crystal structure, the first 
two β-strands from the β-sheet subdomain of one monomer have switched with the 
equivalent subdomain portion of the second monomer. Interestingly, the subdomain-
swapped elements from the XcPqqD crystal dimer retain very similar packing between 
the α-helices and β-sheet as observed in the MePqqD monomer (Figure 19). The RMSD 
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for α-carbons of the XcPqqD core fold (β1–β2 from one monomer and β3, α1–α3 from 
the second) and the MePqqD core fold was 1.72 Å. This indicates remarkable similarities 
of the fold between the NMR structure for MePqqD and the subdomain-swapped 
monomer from the XcPqqD crystal structure. 
The β-strands and α-helices in MePqqD also closely match the constituent RRE folds 
seen in three PRPS biosynthesis enzymes for which crystal structures in complex with 
peptide exist: Lactococcus lactis NisB (PDB entry 4WD9), a lanthipeptide dehydratase in 
the biosynthesis pathway of nisin;116 Lyngbya sp. PCC-8106 LynD (PDB entry 4V1T), a 
fused cyclohydratase involved in cyanobactin biosynthesis;117, 118 and E. coli MccB (PDB 
entry 3H9Q), an adenylating enzyme in the microcin C7 pathway119 (Figure 26). 
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Figure 26. Comparison of PqqD to RREs from other PRPS enzymes in complex with 
peptide. (A) NisB, PDB 4WD9 (residues 142–223), (B) LynD, PDB 4V1T (residues 1–
81), and (C) MccB, PDB 3H9J (residues 1–78). Constituent RREs with bound 
peptides are shown as cartoon and colored by secondary structure with bound 
precursor peptides drawn as stick and colored purple. The enzyme of which the 
RRE is a part is shown as a gray molecular surface. (D) PqqD residues perturbed by 
binding PqqA and the rSAM enzyme, PqqE, are colored purple and green, 
respectively. The peptides of NisB and LynD crystal structures are overlaid based 
on superposition of the RREs with PqqD (NisB peptide, light blue; LynD peptide, 
dark blue). (E) Precursor peptide sequence comparison between NisB, LynD, and 
PqqD. The peptide residues observed in the NisB and LynD crystal structures are 
white in colored boxes. The most proximal residue that is post-translationally 
modified is colored red. 
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PqqA binding to PqqD 
Chemical shift perturbations observed during substrate binding can be caused directly 
by noncovalent interactions with either solvent molecules or binding partners, or 
indirectly by alterations to the conformational environment of residues not in direct 
contact. Via comparison of the residues that showed the greatest chemical shifts in the 
PqqD–PqqA 1H,15N-HSQC spectrum with the peptide positions in the NisB, LynD, and 
MccB crystal structures, PqqA appears to bind to a region on the surface of PqqD similar 
to that of the peptides of NisB and LynD (Figure 26D).116, 120 In the case of MccB, the 
substrate, MccA, is a heptapeptide, one of the shortest RiPP substrates known, and the 
short length does not allow substantial interactions with the MccB RRE (Figure 26C).119 
As such, the MccB–MccA interaction is likely atypical with contact limited to one end of 
the RRE β-sheet, principally through the side chain of MccA Arg2. In the cases of NisB 
and LynD, the peptide forms an additional β-strand to the core β-sheet with the expected 
main chain hydrogen bonds to β3, and this constitutes the defining, major interaction with 
the RRE. In the case of PqqD, the β3 strand chemical shifts are significantly perturbed, 
suggesting that PqqA may also form a β-strand with the PqqD β-sheet. The residues prior 
to those within the β-strand adopt different conformations in the NisB and LynD peptides 
(Figure 26). Despite this, both the NisB and LynD peptide side chains in this region 
interact with the N-terminal α3 helix side chains and primarily involve bulky 
hydrophobic residues, such as Leu, Tyr, and Phe. However, it should be noted that the 
first four ordered residues of the LynD peptide are in a substantial crystal contact that 
may influence the conformer observed in this particular case. Although the binding of 
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PqqA does not lead to large chemical shift perturbations in the α3 helix of PqqD, it is 
likely that there are interactions between these two elements. Interestingly, residues at the 
N-terminus of the α1 helix of PqqD show large chemical shift changes when complexed 
to PqqA (Figure 25). This could suggest that PqqA folds over the saddle between strand 
β2 and helix α2 of PqqD in a direct interaction, but the effect could also indirectly arise 
from the interaction between PqqA and strand β3 of PqqD, which is immediately N-
terminal to helix α1. 
PqqE binding to the PqqD–PqqA complex 
For NisB, LynD, and MccB, the enzyme portion of the RRE-enzyme superstructure 
interacts with the RRE domain such that the β3–α1 and α2–α3 loops and the associated 
ends of those secondary structures are solvent exposed (Figure 26A–C). Results from the 
PqqD–PqqA–PqqE binding experiments indicate that the positioning of PqqD relative to 
PqqE is similar to the position seen in the RRE-enzyme superstructures of NisB, LynD, 
and MccB (Figure 26). RiPP precursor peptides are bipartite, with an N-terminal leader 
sequence involved in RRE-to-precursor peptide recognition, and a C-terminal core 
sequence that contains the residues ultimately comprising the final RiPP natural 
product.11 Because the C-terminal core portion of PqqA must insert into the active site of 
PqqE, it is likely that the peptide is oriented such that the N-terminal end is close to the 
α2–α3 loop and the C-terminal end of the leader of PqqA lies at the β2–β3 loop, as 
observed in NisB and LynD. While the NisB and LynD leader sequences of the 
respective precursor peptides contain 23 and 43 residues, the peptide segments for which 
electron density was observed and modeled were only 13 and 15 residues long, 
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respectively, and represent only the residues critical to recognition (Figure 26E).120, 121 In 
both cases, the amino acids bound to the RRE domain are significantly upstream from the 
start of the core peptide on which the enzyme acts (8 residues in NisB and 9 residues in 
LynD). In both cases, the active sites are relatively distant from the last ordered residue 
of the precursor peptide bound by the RRE (LynD, > 25 Å; NisB, > 30 Å). In contrast, 
the entire leader of PqqA is a similar length to the ordered peptide observed in the LynD 
and NisB crystal structures, with only 14 residues N-terminal to the Glu residue that is 
cross-linked to Tyr through the action of PqqE.45 These observations suggest that the 
majority of the PqqA leader is likely bound to PqqD, placing the PqqA EXXXY core 
sequence very close to the RRE with few intervening residues such that the interaction 
between PqqD and the PqqE active site may be quite intimate. PqqE is a rSAM enzyme, 
and the chemistry must be sequestered from solvent.61 Although the structure of PqqE is 
currently not known, an additional function of PqqD may be to act as a plug to prevent 
quenching of the radical by solvent during turnover.61 This is in contrast to LynD and 
NisB, both dehydratases, where reaction byproducts need to exit the active site 
(ADP/phosphate and glutamate, respectively), and the RRE domains are more distant.116, 
120 This additional function may be specific to RiPPs whose biosynthesis involves rSAM 
enzymes, suggesting that even if the RRE is part of the polypeptide of the rSAM enzyme, 
it may require more mobility than the RRE domains of NisB, LynD, and MccB require. 
Supporting the hypothesis that PqqD acts as a plug is the presence of a long linker (26 
residues) seen in the MePqqCD natural fusion (Figure 23). 
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It should be noted that the NMR experiments with PqqE were conducted aerobically, 
which means that the active site and SPASM domain Fe-S clusters were oxidized, and 
probably partially occupied; even the anaerobically isolated PqqE contains incomplete 
clusters that need to be reconstituted.45 In addition to the [4Fe-4S] cluster of the rSAM 
active site, the PqqE SPASM domain contains a [4Fe-4S] and a second cluster that may 
be a [2Fe-2S].45, 122 Electron paramagnetic resonance data indicate that the binding of 
PqqD affects at least one of the [4Fe-4S] clusters, which is consistent with the hypothesis 
that PqqD must bind in the proximity of the active site.114 
It is becoming clear that rSAM-SPASM enzymes are widespread (∼14000 annotations 
in the Interpro sequence database), particularly in association with RiPPs. The prevalence 
of rSAM enzymes in RiPP biosynthesis (both with and without SPASM domains) is 
likely linked to the inherent ability of radicals to initiate peptide chemistry. 
Bioinformatics suggests that ∼50% of all RiPP rSAM-SPASM enzymes have an 
identifiable N-terminal RRE domain as part of the polypeptide, although in mycofactocin 
biosynthesis, like PQQ, the RRE is present as a separate protein, MftB.44, 53, 54 The 
chemistry catalyzed by these enzymes includes carbon−carbon bond formation (PqqE45 
and StrB123), oxidative decarboxylation (MftC53, 54), and thioether bond formation 
(AlbA,55, 56 SkfB,57, 58 ThnB,59 and SCIFF maturase60). The final RiPP products are 
chemically diverse with a wide range of physiological functions: antibiotic (thurincin H 
and subtilosin A), growth regulation (sporulation killing factor), signaling (streptide), and 
redox cofactors (PQQ). Unfortunately, the only crystal structure of a rSAM-SPASM 
enzyme is that of anSME, which is not part of a RiPP pathway but activates a sulfatase 
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under anaerobic conditions through post-translational modification.62 Therefore, the 
structural details of how peptide substrates are presented to the prevalent rSAM-SPASM 
enzymes found within diverse RiPP biosynthesis pathways are currently unknown. This 
work provides the first insight by identifying residues in PqqD that interact with PqqE 
and showing that the binding surface overlaps with that of PqqA. 
In conclusion, the first detailed monomeric structure of PqqD is presented. Mapping 
of chemical shifts perturbed by binding of PqqA, the precursor peptide, demonstrates that 
the binding mode of the PqqA leader peptide is likely similar to that observed in crystal 
structures of the unrelated dehydratases, LynD and NisB, utilizing a cleft formed between 
helix α3 and strand β3. The length of the ordered leader peptide bound to the RREs of 
LynD and NisB suggests that the core EXXXY residues of PqqA lie adjacent to the 
PqqD-bound peptide. This suggests that the PqqE active site lies very close to PqqD in 
the ternary complex, so PqqD may play the additional role of sequestering the PqqE 
radical intermediate from solvent. Structural work to precisely define these interactions is 
currently underway. 
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CHAPTER 4 
 
This chapter is intended for future publication in Acta Crystallographica Section F 
 
Crystal structure of Methylobacterium extorquens AM1 PqqC from the natural 
PqqCD fusion and the PqqC truncation 
Robert L. Evans III, Morgan Esler, John A. Latham, 
Judith P. Klinman, Carrie M. Wilmot 
 
Paper 3 Abstract 
Two crystal structures for PqqC, the final enzyme in the pyrroloquinoline quinone 
(PQQ) biosynthesis pathway, are reported. Both protein constructs are derived from 
Methylobacterium extorquens AM1 (Me) PqqCD (one, the full-length protein, and the 
other, the PqqC-domain truncation). MePqqCD and MePqqC constructs crystallized in 
space groups, P41212 and P212121, respectively, and the structures demonstrate that the 
MePqqC truncation has the native fold of the full-length protein. Additionally, MePqqCD 
and MePqqC are very similar to the published crystal structure of Klebsiella pneumoniae 
PqqC. However, the small PqqD domain of the MePqqCD crystal structure could not be 
modeled, as it forms no crystal contacts and is disordered in the solvent channels of the 
crystal. 
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INTRODUCTION 
First characterized by J.G. Hauge in 1964, pyrroloquinoline quinone (PQQ) is a 
cofactor for prokaryotic aldose sugar and alcohol dehydrogenases.1, 4-6, 15, 72 PQQ is 
synthesized independent of its affiliated dehydrogenase enzymes, functioning in these 
periplasmic dehydrogenases as an electron acceptor. This allows for the direct utilization 
of energy from applicable sugars and alcohols, and gives the bacteria a competitive 
growth advantage.2 Interestingly, PQQ also enhances bacterial growth rates in species 
that do not synthesize the molecule.6, 93, 94 
In addition to acting as a bacterial cofactor and vitamin, PQQ exhibits probiotic 
properties in eukaryotes, including: acting as a potent antioxidant;31-33 contributing to 
mitochondriogenesis;24-30 providing mammalian growth and reproduction benefits;19-22 
maintaining nervous tissue health;124-127 and promoting plant growth.73 
PQQ is classified as a ribosomally produced, post-translationally modified peptide 
(RiPP) biosynthesized by a comparatively simple post-ribosomal peptide synthesis 
(PRPS) pathway.11 Just as PQQ is biochemically intriguing on its own, the biosynthetic 
pathway itself is also of broader interest as its simplicity makes it a model RiPP system 
for testing bioengineering strategies aimed at generating novel therapeutics based on 
other RiPP pathways.11 
PQQ biosynthesis requires only five gene products from the pqq operon in Klebsiella 
pneumoniae (Kp): PqqA, the precursor peptide from which all nitrogens and carbons 
comprising PQQ originate; PqqB, a putative oxygenase; PqqC, an oxidase and the final 
enzyme in the pathway; PqqD, a scaffolding protein that presents PqqA to PqqE, a radical 
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S-adenosyl-methionine enzyme that initiates the pathway. A sixth protein, a putative 
protease PqqF, occurs in many species including Kp, but can be deleted with no 
phenotypic effects.2, 44, 50, 97 
PqqC completes the synthesis of PQQ via four, two-electron transfer steps (eight 
electrons total), oxidizing and cyclizing AHQQ [3a-(2-amino-2-carboxyethyl)-4,5-dioxo-
4,5,6,7,8,9-hexahydroquinoline-7,9-dicarboxylic acid] to PQQ in the final step of the 
pathway (Figure 27).47-50, 52 
PqqC is interesting because it activates oxygen without a metal nor redox prosthetic 
group (such as a flavin).50 During the four two-electron cyclization/oxidation steps, either 
a dioxygen or a hydrogen peroxide molecule is reduced. In the case of O2 as the electron 
acceptor, spin-forbidden, two-electron transfers from the substrate may be accomplished 
by two, single-electron transfers allowing time for spin-inversion to circumvent the 
formally spin-forbidden transfer.128 This mechanism differs from how other oxidases that 
include redox cofactors activate dioxygen, as AHQQ itself plays dual roles of substrate 
and cofactor.129-135 Therefore, PqqC is an intriguing member of a select group of oxidases 
classified as “cofactorless”.50 Understanding the diverse mechanisms employed in nature 
for controlled oxygen activation from the triplet to singlet state are critical to 
fundamentally understanding aerobic biology. 
While PqqC and PqqD are naturally fused in Methylobacterium extorquens AM1 
(Me), MePqqD expressed from a truncated MepqqCD construct is natively folded and 
acts as a fully functional RiPP recognition element (RRE).45, 136 Here we demonstrate that 
the MePqqC truncation is also natively folded when compared to the crystal structure of 
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the full-length MePqqCD, and we discuss the structure of MePqqC in relation to the 
previously published KpPqqC. 
 
Figure 27. The substrate for PqqC, AHQQ, is converted to PQQ in a multistep, 
eight-electron cyclization (A) and oxidation (B, C, D). Dioxygen is the electron 
acceptor in steps A, B, and D. Hydrogen peroxide is the electron acceptor in step C. 
Graphic adapted from Scheme 1 of Bonnot, et al., (2013).50 
 
MATERIALS AND METHODS 
Cloning, gene expression and protein purification 
Materials 
The restriction enzymes used in all procedures came from New England BioLabs 
(Ipswich, MA), as did the T4 DNA ligase. All DNA constructs were sequenced by the 
University of California DNA Sequencing Facility (Berkeley, CA). Agilent (Santa Clara, 
CA) provided the Pfu Turbo polymerase, and Eurofins (Huntsville, AL) supplied 
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oligonucleotide primers. The pET28a vector was purchased from EMD Millipore 
(Bedford, MA). BL21 Gold (DE3) competent cells were from Agilent/Stratagene (Santa 
Clara, CA). PD-10 and HisTrap FF columns were products of GE Healthcare Life 
Sciences (Marlborough, MA) 
Expression and purification of recombinant PqqCD 
The N-terminal His6-tagged MepqqCD (UniProt entry Q49150) gene (Figure 28A,B) 
was PCR amplified using Methylobacterium extorquens AM1 (ATCC, Manassas, VA) 
DNA as the template, purchased oligonucleotides as primers, and Pfu Turbo as the 
polymerase. 
 
Figure 28. (A) The primary sequence for MePqqCD natural fusion with the linker 
region colored green and the C-terminal PqqD domain in blue. (B) The recombinant 
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MePqqCD protein construct, with the N-terminal His6-tag is red. (C) The MePqqC 
truncation, with the His6-tag colored red and a small portion of the linker region 
colored green. 
 
Products of the PCR amplification were digested using Xhol and NdeI and were 
subsequently purified by way of electrophoresis through agarose gel, after which the 
products were ligated into similarly-digested pET28a vectors using T4 DNA ligase. 
Sequence verification was performed on the cloned gene, which was then used to 
transform Escherichia coli BL21(DE3) cells. The MePqqCD/pET28a-transformed E. coli 
BL21(DE3) cells included an N-terminal His6-tag for post-expression, IMAC 
purification. Cell grow-up, in LB media containing 50 µg/ml kanamycin, was maintained 
at 37 °C. Production of His6-MePqqCD was induced by the addition of 1 mM isopropyl-
D-galactopyranoside once the cell density had reached A600 ~ 0.6. TCEP (1 mM) was 
added to all buffers used in purification to prevent intermolecular disulfide bond 
formation. The induction period was 12 hours, during which temperature was maintained 
at 19 °C. Cells were harvested by 10 minutes of centrifugation at 6,500 rpm. Cells were 
resuspended in a buffer volume equaling five times the mass of cell paste. The buffer 
solution consisted of 50 mM imidazole, 50 mM Tris, pH 7.9, and 200 mM sodium 
chloride (lysis buffer). Cells were lysed using ultrasonication, and the lysate was 
centrifuged for 15 minutes at 20,000 rpm. The supernatant was loaded onto one 5-ml 
HisTrap FF column, which was then washed at 4 °C with lysis buffer to remove 
unwanted protein and then with elution buffer (consisting of 300 mM imidazole, 50 mM 
Tris, pH 7.9, and 200 mM sodium chloride) to elute the MePqqCD. The desired fractions 
were combined, concentrated, and buffer exchanged over PD-10 columns equilibrated 
  78 
with 50 mM Tris, pH 7.9, 150 mM sodium chloride, and 1 mM TCEP. The combined 
sample was flash frozen in liquid nitrogen. SDS-PAGE analysis confirmed homogeneity. 
Final yield for the His6-MePqqCD construct (Figure 28B) was 24 mg per liter of culture. 
Expression and purification of recombinant PqqC 
The DNA sequence encoding for the N-terminal His6-tagged PqqC-domain truncation 
(residues 1-266, Figure 28C) of M. extorquens AM1 PqqCD (Uniprot entry Q49150) 
amino acid was amplified from genomic DNA (ATCC) and cloned into the Nde/XhoI 
restriction sites of pET28a. The sequence verified pqqC/pET28a plasmid was used to 
transform BL21 Gold (DE3) cells. An overnight culture was used to inoculate 4 L of LB 
broth and was then grown at 37o C to an A600 ~ 0.6. Upon reaching the indicated A600, 
His6-PqqC production was induced by the addition of 0.5 mM IPTG and the temperature 
was reduced to 20o C overnight. Cells from an overnight culture were harvested by 
centrifugation and suspended in lysis buffer (50 mM Tris, 200 mM sodium chloride, 30 
mM imidazole, pH 7.9). Cells were lysed by sonication and clarified by centrifugation at 
20,000 g for 10 minutes. The clarified lysate was applied to a 5 mL HisTrap FF column, 
after which the column was washed with 25 mL of lysis buffer. PqqC protein was eluted 
from the column with elution buffer (50 mM Tris, 200 mM sodium chloride, 300 mM 
imidazole, pH 7.9). Fractions containing purified PqqC as determined by SDS-PAGE, 
were pooled, concentrated, buffer exchanged into storage buffer (50 mM Tris, 100 mM 
sodium chloride, pH 7.9), and flash frozen in liquid nitrogen. Yield for the PqqC-domain 
protein construct was ~15 mg per liter of cell culture. 
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Screening, crystallization, and data collection 
Crystallization screening was performed on a Rigaku CrystalMation robot. Each well 
contained 50 µL screening solution and each sitting drop contained 100 nL protein 
solution plus 100 nL well solution. Sealed plates were incubated at 20º C and the 
crystallization drops were digitally photographed using a Minstrel HT Imager. The 
generated images were inspected through a web interface provided on an internal 
CrystalTrak server. Candidate "hits" were optimized and screened for diffraction in-house 
on a Rigaku MSC Micromax 007 HFM X-ray generator equipped with a Saturn 944+ 
CCD Camera and an Oxford cryostream. 
MePqqCD 
Crystals were grown under hanging drop vapor diffusion conditions in 24-well VDX 
Plate trays with 500 µL crystallization volumes in the wells (Hampton Research). Drops 
were suspended from 22mm siliconized glass cover slips (Hampton Research). Protein 
solution was 8.0 mg/mL protein in 50 mM Tris, pH 7.9, 100 mM sodium chloride, and 1 
mM TCEP. Well solution was 100 mM HEPES, pH 6.7, 19% w/v PEG-4000, and 10% 
isopropanol. The water used in the well solution contained 0.55 mM sodium azide for 
fungal growth suppression. The hanging drops were created by addition of 1 µL well 
solution to 1 µL protein solution. Trays incubated for 3 to 4 weeks before 0.5 µL of 0.08 
mg/mL PQQ solution was added to each drop, after which, crystals appeared within 2 
days. Oddly, crystallization would not commence without the addition of PQQ, but there 
was no evidence of PQQ binding in the resultant electron density. Crystals were generally 
needle-like, with the largest, best diffracting specimens reaching 20 µm × 20 µm × 400 
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µm. Before data collection, the crystal was transferred to a cryo-solution consisting of 
25% glycerol and 75% well solution for ~30 s and was then flash-cooled in liquid 
nitrogen. Data were collected at 100 K on the Advanced Photon Source (APS) beamline 
23-ID-D (GM/CA) of Argonne National Laboratory, Argonne, IL, USA using the 
JBluIce-EPICS software137 and a Dectris Pilatus3-6m detector. 
MePqqC truncation 
The same hanging drop vapor diffusion set-up used for MePqqCD was used for the 
MePqqC truncation. Protein solution was 8.0 mg/mL protein in buffer containing 50 mM 
Tris, pH 8.0, and 200mM sodium chloride. Well solution was 100 mM HEPES, pH 8.1, 
200 mM sodium chloride, and 23.75% w/v PEG-3350. All water used in well solution 
buffers contained 0.55 mM sodium azide. The protein solution to well solution ratio was 
1:1 (1 µL to 1 µL). Unlike the MePqqCD trays, PQQ was not added to these drops. 
Crystals appeared after 1 to 3 weeks. The best diffracting crystal measured 170 µm × 290 
µm. The crystal was cryoprotected in 25% glycerol and 75% well solution for 
~30 s and flash-cooled in liquid nitrogen. X-ray diffraction data were collected at 100 K 
on APS beamline 23-ID-D using the JBluIce-EPICS software137 and Dectris Pilatus3-6m 
detector. 
Structure determination 
Both data sets were integrated and scaled using XDS138, 139 with integrated JBluIce 
pipeline automation developed by APS beamline 23-ID-D. 
The 2.00 Å resolution dataset for MePqqC was phased first, and the resultant 
structure was then used to phase the 2.85 Å resolution MePqqCD dataset. MePqqC was 
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phased by molecular replacement with the single search model derived from the 
published KpPqqC coordinates (PDB entry 1OTV).48 The search model was derived by 
manually editing away loop regions, and by pruning dissimilar side chains back to Cβ 
atoms using a text editor and Chainsaw.140 Molecular replacement was carried out using 
Phaser141, 142 implemented in the CCP4 suite.143 A single solution, with four molecules in 
the asymmetric unit, was predominant, with RFZ = 3.3, TFZ = 20.4, PAK = 0, LLG = 
1057. After several rounds of phase improvement and model building using Refmac5143 
and Coot,144 and building only one of the polypeptide chains using the best monomer 
(chain A) electron density of the four monomers comprising the asymmetric unit (AU), a 
new search model was created and the original dataset was again processed with Phaser. 
The improved search model again gave a single solution with four molecules in the AU, 
but this time with an RFZ = 10.9, TFZ = 85.1, PAK = 0, and LLG = 14183. Following 
this, cycles of model building of all four chains of the AU and refinement were 
performed to yield the final model. MolProbity110, 145 was used for structure validation 
and correction. The final run with Refmac5 included TLS refinement. 
The dataset for MePqqCD was phased by molecular replacement using an MePqqC 
monomer (from above) as the search model. As with the MePqqC crystal, the single 
solution provided by Phaser for MePqqCD had four molecules in the AU and an RFZ = 
4.2, TFZ = 29.3, PAK = 0, and LLG = 4755. Refinement and validation were carried out 
as described above for MePqqC. 
All figures were prepared with MacPyMOL (http://www.pymol.org ).113 
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RESULTS AND DISCUSSION 
Data collection statistics 
The best diffracting crystal for both constructs yielded data collection and refinement 
statistics summarized in Table 3. 
Table 4. Data collection and refinement statistics. 
 
*When used, values in parentheses are for the highest resolution shell. 
aRfree is the R factor based on 5% of the data excluded from refinement. 
bValue calculated by MolProbity (http://molprobity.biochem.duke.edu/). 
Refinement was carried out in Refmac version 5.8.0158. 
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Phasing and refinement results 
Refinement resulted in models with statistics as expected for the respective 
resolutions achieved, 2.85 Å for MePqqCD and 2.00 Å for MePqqC (Table 4). The final 
models both contain four molecules of PqqC in the AU. MePqqCD crystallized in space 
group P41212 and MePqqC crystallized as P212121. Although the MePqqCD protein 
construct included the PqqD-domain, no electron density was found and the domain 
could not be modeled. 
Discussion comparing MePqqCD to the MePqqC truncation 
No ordered water molecules were modeled for the lower resolution, MePqqCD, structure. 
A total of 84 waters were modeled into the higher resolution, MePqqC truncation, model. 
The crystallographic data for both proteins have been deposited in the Protein Data Bank 
(MePqqCD as PDB entry 5VRD and MePqqC as entry 5VRC). 
The His6-MePqqC truncation contained 288 residues (Figure 28C). Electron density 
for the 22-residue His6-tag was not found for any of the 4 molecules in the AU indicating 
it was disordered and mobile. Protein residues that were modeled are as follows (residue 
numbering where 1 = the first residue of the actual gene product, not the His6-tagged 
construct): 
Chain A includes 228 residues: 14–162, 169–188, 200–258 
Chain B includes 235 residues: 15–163, 166–190, 199–259 
Chain C includes 227 residues: 15–162, 170–171, 173–189, 200–259 
Chain D includes 224 residues: 16–157, 169–188, 198–259 
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His6-MePqqCD contained 394 residues (Figure 28B). As in the truncation above, no 
electron density supporting the 22-residue His6-tag was found, and further, no density 
supported residue modeling for the PqqC–D linker or the PqqD-domain, although ample 
solvent channel space at the C-terminal ends of the PqqC-domains would have allowed 
for the PqqD-domains (Figure 29). Protein residues that were modeled are as follows 
(again, residue numbering where 1 = the first residue of the gene product): 
Chain A includes 210 residues: 15–98, 102–162, 173–179, 182–185, 199–252 
Chain B includes 209 residues: 16–99, 102–162, 173–180, 197–252 
Chain C includes 196 residues: 17–31, 33–98, 104–162, 175–179, 199–249 
Chain D includes 204 residues: 19–31, 33–97, 102–162, 173–190, 199–245 
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Figure 29. MePqqCD crystal packing. Rhomboidal solvent channels, ~ 45 Å to a 
side, run the length of the crystal, providing ample space for the 26-residue linker 
and 11 kDa PqqD-domain. The C-terminal ends for each of the four chains (red 
spheres) are all adjacent to these channels. 
 
Average root mean square deviations (RMSDs) between the various chains for 2.85 Å 
MePqqCD (4 chains per AU), 2.00 Å MePqqC truncation (4 chains per AU), and 2.10 Å 
KpPqqC (PDB entry 1OTV, 2 chains per AU), were performed using the PyMol 'super' 
command, with cycles = 0. The RMSD alignments were performed using C-alphas. The 
  86 
average RMSD between intramolecular chains in MePqqCD is 0.536 Å (population 
standard deviation (PSD 0.0972 Å)). The average RMSD for intramolecular chains in the 
MePqqC truncation is 0.730 Å (PSD 0.239 Å). When comparing all four chains from 
MePqqCD with all four chains from the MePqqC truncation, the RMSD is 0.927 Å (PSD 
0.162 Å) demonstrating that the MePqqC structures are essentially the same (Figure 30). 
Both are in an “open” conformation where helices five and six are highly disordered, 
allowing for AHQQ/PQQ entry/departure (Figure 31A, gray helices). If the substrate was 
bound, the enzyme would have taken on a “closed” conformation, as seen in the 
KpPqqC-PQQ product complex (Figure 31B).48 
 
Figure 30. C-alpha traces of all four chains in the MePqqCD model (from A–D: 
green, green/cyan, light blue, dark blue), plus all four chains in the MePqqC 
truncation model (from A–D: brown, red, orange, yellow), plus the two chains in the 
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KpPqqC (PDB entry 1OTV) (chain A, violet; chain B, black). Alignments 
performed using the PyMol 'super' command. 
 
 
Figure 31. Illustrating the open and closed conformations of PqqC. The open (A) 
versus closed (B) conformations of PqqC can be seen in the deposited structures for 
KpPqqC and the KPPqqC-PQQ product complex (PDB entries 1OTV and 1OTW, 
respectively). The most significant differences between the conformations involve 
alpha-helices five and six (labeled and colored gray); in the absence of product (and 
presumably substrate) they are much more disordered. Once substrate binds, the 
helices become more ordered, although unpublished HDX mass spectrometry and 
fluorescence data from our collaborators in the Klinman lab, suggest that closure 
occurs progressively during the reaction. PQQ is colored red in panel B. 
 
The tertiary structure for MePqqC and MePqqCD are in the open conformation 
(Figure 32). Both models show a seven helical bundle identical to the tertiary structure in 
KpPqqC.48 Alpha-helix one (residues 19–46) is disrupted at residues 34–38. The longest 
helices in the open conformation, helices two and seven (residues 51–78 and 212–241, 
respectively), are continuous and highly ordered. Similar to helix one, helices three and 
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four (residues 82–115 and 119–145, respectively) are interrupted. Helix three, in 
particular, is interrupted by an interesting feature, a loop (residues 99–103) that appears 
MePqqC, MePqqCD, and in all deposited Kp structures. This highly conserved feature 
may have something to do with substrate binding, as it is adjacent to the helices that open 
and close to bind/release AHQQ/PQQ. Helices five and six are comprised of residues 
147–175 and 181–208, respectively (Figure 32). 
  89 
 
Figure 32. As in KpPqqC, MePqqC consists of seven alpha helices (A) arranged in a 
helical bundle (B, C). In the open conformation, illustrated here, helices five and six 
are disordered. The model shown in panel B is for the MePqqC truncation, although 
the PqqC-domain from MePqqCD is essentially identical. Active site residues (Y34, 
H35, Y64, H95, E158, H165, Y186, R190) are represented by boxes (panel A). Due to 
high disorder in helices five and six, active site residues H165 and R190 were not 
modeled. 
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The higher resolution MePqqC truncation structure included more C- and N-terminal 
residues and included fewer and smaller gaps (areas of weak density/high molecular 
mobility). The MePqqC truncation protein contained a few residues of the PqqC–D linker 
region, but only showed electron density for the first linker residue (Val 259). By 
contrast, the MePqqCD protein contained all residues out to and including the PqqD-
domain when the crystallizations were set up, and yet only had electron density up to Trp 
252. There is the possibility that the MePqqCD underwent proteolysis in the hanging 
drop prior to crystal formation, cleaving away part or all of the linker––PqqD-domain, 
and only this truncated protein crystallized. Before submitting this dissertation chapter for 
publication, an SDS-PAGE gel of dissolved crystals from the experimental tray will be 
run to see if the form that crystallized is truncated or appears full-length. If a single 
PqqCD band is observed, the lack of electron density can be attributed to a highly 
disordered linker––PqqD-domain in the large solvent channels (Figure 29). 
Ramachandran analysis showed that the lower resolution MePqqCD structure has 
poorer model statistics, as expected. Only 90.5% (738/815) of all residues were in 
favored regions, and 97.9% (798/815) of all residues were in allowed regions. In 
comparison, for MePqqC, 98.5% (875/888) of all residues were in favored regions, and 
99.8% (886/888) of all residues were in allowed regions. 
Discussion comparing the MePqqC (truncation) to KpPqqC 
The 2.0 Å MePqqC truncation structure is clearly superior to the structure for the 2.85 
Å MePqqCD natural fusion, therefore comparisons to the deposited KpPqqC structure 
(PDB entry 1OTV at 2.1 Å resolution)48 will only be made with MePqqC. Sequence 
  91 
identity between KpPqqC and MePqqC is 41.9% (Clustal Omega (1.2.4), 
www.ebi.ac.uk). The average RMSD on C-alphas for all four chains from MePqqC, 
compared to the two chains from KpPqqC, is 1.71 Å (PSD 0.293 Å). The 2Fo − Fc map 
for three of the active site residues that are conserved between MePqqC and KpPqqC48, 50 
illustrates the quality of the electron density (Figure 33). 
 
Figure 33. MePqqC 2Fo - Fc density for three active site residues. Density was 
contoured at sigma = 1.0, carve = 2.5. The map was calculated using FFT.146 
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The MePqqC crystal structure confirms the presence and positioning of previously 
identified active site residues in KpPqqC.48, 50, 147 MePqqC shows similarly arranged 
residues at the active site (Figure 34, circled residues). 
 
Figure 34. Cartoon structure of MePqqC truncation (cyan) overlaid with KpPqqC 
(green). Active site residues are circled. The helices that contain the active site 
residues His165, Arg190, and Tyr186 are even more disordered in MePqqC than in 
KpPqqC, therefore, these three residues could not be modeled for MePqqC.  
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CONCLUSIONS 
Although PQQ was required to crystallize MePqqCD, no electron density supporting 
the presence of the molecule was observed (Figure 33) and the enzyme was in an "open" 
conformation (Figures 31A, 32B, 34 cyan). This inability (under these crystal conditions) 
to bind PQQ stands in contrast to what has been observed with KpPqqC, where co-
crystallization has proven viable. Electron density supporting PQQ and a putative H2O2 
product has been observed at the active site of KpPqqC (PDB entry 1OTW)48 and 
evidence of bound PQQH2 was seen in the KpPqqC Y175F mutant co-crystallized with 
AHQQ (PDB entry 4NY7).148 Further, attempts to soak PQQ into the MePqqC truncation 
crystals did not lead to PQQ binding either, and when PQQ was added in excess, the 
MePqqC truncation crystals rapidly dissolved (~30 s). 
The MePqqC substrate entry helices (helices 5 and 6) appear to be accessible through 
solvent channels and do not appear to be involved in crystal contacts (Figure 29), but they 
do show a higher level of disorder (a lack of electron density and fewer modeled 
residues) than what is seen in KpPqqC (Figure 34) even though the two structures are of 
similar resolutions (KpPqqC is 2.1 Å and MePqqC is 2.0 Å). Therefore, there would be a 
higher entropic cost to binding PQQ. In the MePqqC crystals, addition of higher 
concentrations of PQQ led to the crystals dissolving, suggesting that the crystal packing 
could not survive the disorder-to-order transition that occurs upon PQQ binding. 
Regardless of our ability to capture PQQ in the active site, there are now two 
additional PqqC structures from another organism deposited in the PDB, entry 5VRC for 
MePqqC and entry 5VRD for MePqqCD. 





NMR accomplishments (PqqD-related) 
Success in solving the solution NMR structure for the MePqqD truncation means that 
the first detailed monomeric structure of PqqD (physiological form) is now available in 
the PDB (entry 5SXY). More than that, this structure represents the first independent 
RRE to be deposited to the PDB and is, even further, the first structure of an RRE that is 
involved with a PRPS rSAM-SPASM enzyme. 
The binding studies for the PqqD–PqqA and PqqD–PqqA–PqqE complexes, show 
that the majority of the PqqA leader is likely bound to PqqD, placing the PqqA EXXXY 
core sequence very close to the RRE with few intervening residues. This proximal 
positioning indicates that the interaction between PqqD and the PqqE active site may be 
quite close and critical. PqqE is a radical-generating rSAM enzyme,45 and in addition to 
PqqD's RRE roles of peptide recognition, binding, and presentation,11, 42, 44 an additional 
function of PqqD may be to shield the tailoring enzyme's active site chemistry from 
radical-quenching solvent. 
XRC accomplishments (PqqC-related) 
While we were eventually able to crystalize both MePqqCD and the MePqqC 
truncation, neither of these crystals took up PQQ in soak experiments, making them 
unsuitable for trapping intermediates via anaerobic soaks. However, they could be useful 
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in anaerobic co-crystallization experiments with AHQQ, and I suggest this below. So, 
while neither crystal form showed promise for soaking experiments, we did contribute 
two new structures to the PDB (entry 5VRC represents the MePqqC truncation and entry 
5VRD represents MePqqCD, both entries are on hold pending publication of paper 3 
(chapter 4 of this dissertation)). 
XRC accomplishments (PqqB-related) 
PqqB crystallographic studies were ultimately transferred to Chao Li, in the Wilmot 
Lab, but prior to that transfer, I was able to solve a structure for the Pseudomonas putida 
PqqB homodimer complexed with zinc (active site physiological metal is thought to be 
copper) and a pre-AHQQ mimic, 5-S-cysteinyl-DOPA (Figure 5). The true pre-AHQQ 
molecule is expected to contain three carboxyl moieties, rather than the two contained in 
5-S-cysteinyl-DOPA mimic. The lack of the additional carboxylate group in the mimic 
led to ambiguous electron density that supported multiple binding conformations. Chao 
and his collaborators in the Klinman Lab, are pursuing better pre-AHQQ mimics. 
Other significant XRC accomplishments (a project not included in this dissertation) 
In a collaboration with Bryan Jones (Kazlauskas Lab, BMBB, UMN), I assisted in 
solving the crystal structure of a possible ancestral hydroxynitrile lyase derived by 
extrapolation back from two modern, plant enzymes belonging to the α/β-hydrolase 
superfamily. My work included guiding Bryan through the process of crystal growth 
screening, crystal optimization, cryoprotection, harvesting/mounting, data collection both 
in-house and at the synchrotron, data processing, phasing, refinement, and deposition. 
Publication of this work is underway. 
  96 
Summary of structures 
During my time as a graduate student in the Wilmot Lab, I either directly or 
indirectly, solved numerous structures, four that are currently deposited in the RCSB 
PDB, and three that are works in-progress (Table 5). 




Experiments to determine PqqA residues involved in binding 
HSQC titrations using specific peptide leader sequence mutations could elucidate 
RRE–peptide (PqqD–PqqA) recognition and binding permissiveness, ultimately 
informing bioengineering efforts.11 Chemical shifts (peak migrations) from these HSQC 
titration experiments could be used to calculate KD values for each construct, provided 
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binding is not too tight (where KD values are ≥ ~3 µM).149 Surface plasmon resonance 
(SPR) spectroscopy would also be useful for examining association/dissociation kinetic 
values (kon and koff)for the binary complex.150 NMR HSQC experiments, in comparison, 
provide information on the relative involvements of specific residues in binding (greater 
weighted peak shift changes indicate more significant changes in individual chemical 
environments for residues). Isothermal titration calorimetry (ITC) can also provide 
binding information (e.g. the dissociation constant, KD), but, like SPR, provides overall 
information about peptide construct binding, rather than information about the relative 
interactions of specific peptide residues.150 ITC and SPR have the advantage of not 
requiring isotopically-labeled PqqD (or PqqA) and, therefore, cost less. 
NMR experiments to solve binary structure 
We know the orientation of PqqD to PqqE in the PqqD–PqqA–PqqE complex 
(Figures 25 and 26D), and from this information, can infer the orientation of PqqA with 
respect to PqqD (the C-terminal core portion of the peptide must be inserted into the 
enzyme for modification, and therefore can only be oriented one way). However, 
knowing the relative positioning of PqqA when bound to PqqD is not the same as having 
a complete structure showing detailed positioning for all residues on both the protein and 
the peptide. Many of the through-bond experiments leading to peak assignment for PqqD 
in the PqqD–PqqA complex, have been completed. The same type of experiments will 
need to be completed for 13C,15N-labeled-PqqA in the PqqD–PqqA complex, in order to 
assign all 1H, 13C, 15N, and peaks for the peptide. Further, NOE (through space) 
experiments will need to be completed for the labeled-PqqD/unlabeled-PqqA, unlabeled-
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PqqD/labeled-PqqA, and isotope-edited labeled-PqqD/labeled-PqqA binary constructs. 
This is a substantial undertaking, every bit as challenging as the work needed for solving 
the stand-alone PqqD structure. The resulting structure will give more details of RRE–
peptide-enzyme interactions. Finally, experiments to define the PqqA residues involved 
in binding will also require PqqE; unlabeled PqqD/labeled PqqA spectra should be 
compared with the unlabeled PqqD/labeled PqqA/unlabeled PqqE spectra to completely 
understand peptide binding dynamics in the contexts of both binary and ternary 
complexation. These experiments will not require labeled PqqE, nor will experiments 
with PqqE include NOEs, as a structure of the ternary complex is not the goal here. 
Crystallography experiments to solve PqqD structure and the binary complex 
Ironically, after failing to find crystallization conditions for PqqD or PqqD–PqqA, 
and then turning to NMR in order to solve the PqqD structure, crystallizing conditions for 
MePqqD were serendipitously discovered while purifying the protein for NMR work. 
MePqqD protein was observed to spontaneously crystallize into thin plates when buffer-
exchanged into pure 25 mM potassium phosphate (pH 6.5) and stored at 4º C. Without 
any further crystal optimization, a crystal harvested from the side of a 50-mL conical 
tube, cleanly diffracted out to 1.72 Å. Multiple data sets were collected, but none were 
able to be phased using molecular replacement (using either the deposited XcPqqD 
domain-swapped dimer (3G2B)63 or the MePqqD solution NMR structure (5SXY)136 for 
search model development). Recently, after over expressing the MePqqD protein using a 
Se-methionine (Se-Met) protocol, Morgan Esler (Wilmot Lab) acquired a 1.96 Å dataset 
collected just above the Se edge, allowing for Se-Met SAD phasing. The resulting 
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structure is currently being used as a molecular replacement search model for the higher-
resolution (1.72 Å) dataset that we were formerly unable to solve. We now know that this 
new MePqqD construct crystallized via a domain swap, as did XcPqqD.63 This 
knowledge will help us understand more about PqqD dynamics and could aid in 
developing strategies for crystallization aimed at binary and ternary complex structures. 
Crystallography experiments to solve ternary complex 
No PqqE structure has yet been deposited in the PDB, although collaborators at the 
Albert Einstein College of Medicine (Bronx, NY) have come close to completing a 3.2 Å 
structure for M. extorquens AM1 PqqE, although it has lost the [4Fe-4S] cluster at the 
rSAM active site. Successes in solving pieces of this complex, as described above, will 
help in phasing datasets collected for a future ternary complex. Eventually, we would like 
to see completed ternary complex structures for not only PqqD–PqqA–PqqE, but for 
other examples of RiPP-initiating RRE–peptide–rSAM-SPASM complexes. 
Crystallography experiments to trap AHQQ-to-PQQ intermediates 
While the crystal forms for MePqqC/CD were unable to bind PQQ in soak 
experiments while retaining crystal integrity, anaerobic co-crystallization of MePqqC/CD 
with AHQQ as the starting point may allow trapping of reaction intermediates through 
introduction of small amounts of oxygen, as was done to trap catalytic intermediates in 
crystals of copper amine oxidase in the Wilmot Lab.151 
Now that we know that the "wild type" KpPqqC structure, for which we were unable 
to replicate crystal growth conditions, was actually an A21D mutant, we can use the 
mutant construct to grow crystals and pursue intermediate trapping as above or through 
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soaking with AHQQ. Single-crystal UV-Vis spectroscopy can be used to corroborate the 
presence of specific intermediates.152, 153 
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